{
  "url": "https://finance.yahoo.com/news/european-market-highlights-3-stocks-054452268.html",
  "authorsByline": "Simply Wall St",
  "articleId": "03d79349ca724b788c94b66177672f34",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-25T05:44:52+00:00",
  "addDate": "2025-08-25T05:59:40.418606+00:00",
  "refreshDate": "2025-08-25T05:59:40.418607+00:00",
  "score": 1.0,
  "title": "European Market Highlights 3 Stocks Estimated Below Intrinsic Value",
  "description": "In recent weeks, European markets have shown resilience, with the STOXX Europe 600 Index climbing 1.40%, driven by optimism around potential rate cuts in the U.S. and a rebound in eurozone business activity. Amidst this positive momentum, identifying stocks that are trading below their intrinsic value can be crucial for investors seeking opportunities to capitalize on market inefficiencies.",
  "content": "In recent weeks, European markets have shown resilience, with the STOXX Europe 600 Index climbing 1.40%, driven by optimism around potential rate cuts in the U.S. and a rebound in eurozone business activity. Amidst this positive momentum, identifying stocks that are trading below their intrinsic value can be crucial for investors seeking opportunities to capitalize on market inefficiencies. Click here to see the full list of 210 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. Overview: Pandora A/S designs, manufactures, and markets jewelry products with a market cap of DKK69.67 billion. Pandora A/S is trading at DKK 912, significantly below its estimated fair value of DKK 1,416.73, indicating potential undervaluation based on cash flows. Despite a high debt level and volatile share price recently, Pandora's earnings are projected to grow at 7.9% annually, outpacing the Danish market's forecasted growth rate of 4.6%. Recent Q2 results showed increased sales and net income compared to last year, supporting its robust cash flow generation capabilities amidst reaffirmed guidance for organic growth in fiscal year 2025.\n\u2022 Our earnings growth report unveils the potential for significant increases in Pandora's future results.\n\u2022 Take a closer look at Pandora's balance sheet health here in our report. Overview: Stora Enso Oyj is a company that offers renewable solutions for the packaging, biomaterials, wooden constructions, and paper industries both in Finland and globally, with a market cap of \u20ac8.28 billion. Operations: The company's revenue is primarily derived from its Packaging Materials segment (\u20ac4.58 billion), followed by Forest (\u20ac3.15 billion), Wood Products (\u20ac1.67 billion), Biomaterials (\u20ac1.57 billion), and Packaging Solutions (\u20ac1.02 billion).",
  "medium": "Article",
  "links": [
    "https://simplywall.st/discover/investing-ideas/168/undervalued-stocks-based-on-cash-flows/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/142929bc-161d-4d6b-8d07-8adf129ab8b9/health?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/8a3231f1-711a-49d1-9395-90e1fe76139e/future?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/8a3231f1-711a-49d1-9395-90e1fe76139e/valuation?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo&amp;blueprint=4014254",
    "https://simplywall.st/company/id/98563a56-5181-46a8-9916-346a18ef6bfa?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/142929bc-161d-4d6b-8d07-8adf129ab8b9/valuation?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo&amp;blueprint=4014254",
    "https://simplywall.st/discover/investing-ideas/10228/fast-growing-stocks-with-high-insider-ownership/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/news/european-market-highlights-3-stocks-estimated-below-intrinsi-1?blueprint=4014254&utm_source=yahoo&utm_medium=finance_user&utm_campaign=integrated-pitch",
    "https://simplywall.st/company/id/142929bc-161d-4d6b-8d07-8adf129ab8b9?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/discover/investing-ideas/152/undiscovered-gems-with-strong-fundamentals/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/98563a56-5181-46a8-9916-346a18ef6bfa/health?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
    "https://feedback.simplywall.st/article/NDAxNDI1NDphYjM1OGRiNDg3OGJlNGZi",
    "https://simplywall.st/company/id/98563a56-5181-46a8-9916-346a18ef6bfa/future?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/8a3231f1-711a-49d1-9395-90e1fe76139e?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/142929bc-161d-4d6b-8d07-8adf129ab8b9/future?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/features/portfolio?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/discover/investing-ideas/146/dividend-powerhouses-3-yield/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/8a3231f1-711a-49d1-9395-90e1fe76139e/health?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
    "https://simplywall.st/company/id/98563a56-5181-46a8-9916-346a18ef6bfa/valuation?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo&amp;blueprint=4014254"
  ],
  "labels": [
    {
      "name": "Roundup"
    }
  ],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "European Market",
      "weight": 0.089338414
    },
    {
      "name": "European markets",
      "weight": 0.089338414
    },
    {
      "name": "market inefficiencies",
      "weight": 0.08371365
    },
    {
      "name": "cash flows",
      "weight": 0.07796774
    },
    {
      "name": "Cash Flows screener",
      "weight": 0.076267116
    },
    {
      "name": "Pandora",
      "weight": 0.075832464
    },
    {
      "name": "potential rate cuts",
      "weight": 0.074543715
    },
    {
      "name": "Intrinsic Value",
      "weight": 0.07272201
    },
    {
      "name": "stocks",
      "weight": 0.07160623
    },
    {
      "name": "organic growth",
      "weight": 0.06822452
    }
  ],
  "topics": [
    {
      "name": "Markets"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.9912109375
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.96533203125
    },
    {
      "name": "/Finance/Investing/Other",
      "score": 0.412353515625
    }
  ],
  "sentiment": {
    "positive": 0.27137062,
    "negative": 0.2859954,
    "neutral": 0.442634
  },
  "summary": "The European markets have shown resilience, with the STOXX Europe 600 Index climbing 1.40% and the potential for potential rate cuts in the U.S. However, identifying stocks that are trading below their intrinsic value can be crucial for investors. The list includes Pandora A/S, which designs, manufactures, and markets jewelry products with a market cap of DKK69.67 billion, which is trading at DKK 912, significantly below its estimated fair value of DKN 1,419.73, indicating potential undervaluation based on cash flows. Despite a high debt level and volatile share price, Pandora's earnings are projected to grow at 7.9% annually, outpacing the Danish market's forecasted growth rate of 4.6%.",
  "shortSummary": "The European market is recovering, with strong investor sentiment and potential rate cuts boosting 3 undervalued European stocks like Pandora A/S trading below intrinsic value based on cash flows.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": false,
  "reprintGroupId": "7b2924f1592c412696c4c0d6645f317e",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://simplywall.st/discover/investing-ideas/146/dividend-powerhouses-3-yield/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014254",
      "text": "Results\n1912\nThis screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.\n1912 companies\nSoliton Systems K.K\nMarket Cap: JP\u00a526.1b\nA technology company, provides IT security-related and embedded systems in Japan and internationally.\n3040\nJP\u00a51,406.00\n7D\n3.0%\n1Y\n34.2%\nCAC Holdings\nMarket Cap: JP\u00a536.6b\nThrough its subsidiaries, provides information technology (IT) services in Japan and internationally.\n4725\nJP\u00a52,142.00\n7D\n0.2%\n1Y\n20.3%\nNCD\nMarket Cap: JP\u00a521.1b\nEngages in the system development, support and service, and parking system businesses in Japan.\n4783\nJP\u00a52,579.00\n7D\n1.1%\n1Y\n36.1%\nTsubakimoto Chain\nMarket Cap: JP\u00a5211.8b\nManufactures and sells chains, motion control, mobility, materials handling systems components in Japan.\n6371\nJP\u00a52,136.00\n7D\n0.05%\n1Y\n7.3%\nSAN Holdings\nMarket Cap: JP\u00a531.6b\nProvides funeral services in Japan.\n9628\nJP\u00a51,543.00\n7D\n-2.1%\n1Y\n31.0%\nHUAYU Automotive Systems\nMarket Cap: CN\u00a559.2b\nResearches and develops, manufactures, and sells automotive parts worldwide.\n600741\nCN\u00a518.79\n7D\n2.7%\n1Y\n38.3%\nPadma Oil\nMarket Cap: \u09f319.5b\nEngages in the procurement, storage, and marketing of petroleum products, lubricants, greases, bitumen, and LPG in Bangladesh.\nPADMAOIL\n\u09f3198.20\n7D\n-1.1%\n1Y\n-5.9%\nDoshishaLtd\nMarket Cap: JP\u00a593.3b\nPlans, develops, produces, and sells lifestyle-related products in Japan and Internationally.\n7483\nJP\u00a52,640.00\n7D\n1.6%\n1Y\n21.4%\nTorigoe\nMarket Cap: JP\u00a522.3b\nManufactures and sells flours and related products in Japan.\n2009\nJP\u00a5957.00\n7D\n1.8%\n1Y\n34.6%\nWuliangye YibinLtd\nMarket Cap: CN\u00a5488.3b\nManufactures and sells liquor and wine products under the Wuliangye brand in China.\n000858\nCN\u00a5125.79\n7D\n2.2%\n1Y\n3.9%\nGakkyushaLtd\nMarket Cap: JP\u00a525.0b\nManages cram schools that offers entrance exams guidance to junior high schools, high schools, and universities in Japan and internationally.\n9769\nJP\u00a52,300.00\n7D\n-0.3%\n1Y\n15.6%\nGuangxi LiuYao Group\nMarket Cap: CN\u00a57.4b\nEngages in the wholesale and retail of pharmaceutical products in China.\n603368\nCN\u00a518.63\n7D\n1.0%\n1Y\n16.7%\nDaicel\nMarket Cap: JP\u00a5362.3b\nEngages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally.\n4202\nJP\u00a51,366.50\n7D\n1.7%\n1Y\n3.2%\nJapan Excellent\nMarket Cap: JP\u00a5196.6b\nJapan Excellent, Inc. (hereinafter, \u201cJEI\u201d), established on February 20, 2006 under the Law Concerning Investment Trusts and Investment Corporations of Japan (the \u201cInvestment Trust Law\u201d), is a real estate investment corporation which primarily invests in office buildings.\n8987\nJP\u00a5147,000.00\n7D\n1.7%\n1Y\n19.7%\nGuaranty Trust Holding\nMarket Cap: \u20a62.4t\nOperates as a financial holding company for Guaranty Trust Bank Limited that provides commercial banking services in Nigeria, Ghana, Gambia, Sierra Leone, Liberia, Cote D'Ivoire, Kenya, Uganda, Rwanda, Tanzania, and the United Kingdom.\nGTCO\n\u20a694.00\n7D\n-3.1%\n1Y\n106.6%\nAudix\nMarket Cap: NT$6.7b\nManufactures, markets, trades in, and distributes electronic components in Taiwan.\n2459\nNT$63.10\n7D\n-2.3%\n1Y\n-12.2%\nMEISEI INDUSTRIALLtd\nMarket Cap: JP\u00a576.8b\nOperates as a construction works company in Japan and internationally.\n1976\nJP\u00a51,614.00\n7D\n-0.2%\n1Y\n27.8%\nChanghong Meiling\nMarket Cap: CN\u00a57.6b\nEngages in the research, development, and manufacturing of refrigeration appliances and washing machines in China and internationally.\n000521\nCN\u00a57.90\n7D\n7.9%\n1Y\n-3.4%\nMidea Group\nMarket Cap: CN\u00a5552.6b\nManufactures and sells home appliances, and robotic and automation systems in China and internationally.\n000333\nCN\u00a572.09\n7D\n-0.3%\n1Y\n10.1%\nLes Docks des P\u00e9troles d'Amb\u00e8s -SA\nMarket Cap: \u20ac95.4m\nEngages in the storage and shipping of petroleum products in France.\nDPAM\n\u20ac975.00\n7D\n0%\n1Y\n85.7%\nTanabe Engineering\nMarket Cap: JP\u00a526.3b\nEngages in plant construction and machinery production activities in Japan.\n1828\nJP\u00a52,508.00\n7D\n-3.6%\n1Y\n49.5%\nZenrin\nMarket Cap: JP\u00a557.9b\nEngages in the collection and management of a range of geospatial information worldwide.\n9474\nJP\u00a51,084.00\n7D\n1.1%\n1Y\n20.3%\nEM Systems\nMarket Cap: JP\u00a552.7b\nDevelops and sells various IT systems for pharmacies, clinics, and care/welfare other business in Japan.\n4820\nJP\u00a5762.00\n7D\n0.1%\n1Y\n34.2%\nGlobal One Real Estate Investment\nMarket Cap: JP\u00a5145.3b\nGlobal One Real Estate Investment Corporation (\u201cGOR\u201d) is a Japanese Real Estate Investment Trust (J-REIT) listed on the Tokyo Stock Exchange (TSE: 8958) with the ultimate goal of pursuing maximum returns for unitholders.\n8958\nJP\u00a5146,400.00\n7D\n1.6%\n1Y\n42.4%\nAiphoneLtd\nMarket Cap: JP\u00a546.2b\nManufactures and sells telecommunications equipment for facilities, offices and public facilities under the AIPHONE brand name for housing, healthcare, business, accessories, and smartphone applications internationally.\n6718\nJP\u00a52,825.00\n7D\n1.1%\n1Y\n-1.1%\nKyosan Electric Manufacturing\nMarket Cap: JP\u00a533.6b\nDevelops, manufactures, and sells electromechanical interlocking, road traffic signal equipment, and cuprous oxide rectifiers in Japan and internationally.\n6742\nJP\u00a5541.00\n7D\n3.8%\n1Y\n0.9%\nKSKLtd\nMarket Cap: JP\u00a526.4b\nEngages in the LSI, software, hardware, customer service, and data entry businesses.\n9687\nJP\u00a54,355.00\n7D\n3.1%\n1Y\n46.6%\nJapan Pulp and Paper\nMarket Cap: JP\u00a584.1b\nEngages in the manufacture, import, export, distribution, wholesale, and sale of paper, paperboards, pulp, and paper-related products in Japan, Europe, Asia, Oceania, North America, and internationally.\n8032\nJP\u00a5683.00\n7D\n2.2%\n1Y\n10.2%\nDN HoldingsLtd\nMarket Cap: JP\u00a517.1b\nEngages in the construction consulting and geological survey businesses in Japan.\n7377\nJP\u00a52,090.00\n7D\n-0.3%\n1Y\n31.0%\nInabataLtd\nMarket Cap: JP\u00a5183.4b\nProvides solutions and services for information and electronics, chemicals, life industry, and plastics businesses in Japan and internationally.\n8098\nJP\u00a53,435.00\n7D\n1.3%\n1Y\n3.8%\nLuzhou LaojiaoLtd\nMarket Cap: CN\u00a5192.4b\nProduces and sells alcoholic products in China and internationally.\n000568\nCN\u00a5130.69\n7D\n4.8%\n1Y\n10.6%\nColumbia Banking System\nMarket Cap: US$5.7b\nOperates as the Bank holding company of Umpqua Bank that provides banking, private banking, mortgage, and other financial services in the United States.\nCOLB\nUS$26.97\n7D\n4.7%\n1Y\n7.7%\nFirst Interstate BancSystem\nMarket Cap: US$3.4b\nOperates as the bank holding company for First Interstate Bank that provides a range of banking products and services in the United States.\nFIBK\nUS$31.99\n7D\n6.5%\n1Y\n4.1%\nRubis\nMarket Cap: \u20ac3.0b\nEngages in the operation of bulk liquid storage facilities for commercial and industrial customers in Europe, Africa, and the Caribbean.\nRUI\n\u20ac29.18\n7D\n-0.07%\n1Y\n1.1%\nZain Bahrain B.S.C\nMarket Cap: \u0628.\u062f42.9m\nZain Bahrain B.S.C. principally engages in the provision of public telecommunications and related products and services in the Kingdom of Bahrain.\nZAINBH\n\u0628.\u062f0.12\n7D\n0%\n1Y\n5.4%\nSelamat Sempurna\nMarket Cap: Rp11.5t\nManufactures and sells tools or equipment for vehicles, heavy equipment, and other machinery in Indonesia and internationally.\nSMSM\nRp1,995.00\n7D\n4.5%\n1Y\n4.5%"
    },
    {
      "url": "https://simplywall.st/company/id/142929bc-161d-4d6b-8d07-8adf129ab8b9/valuation?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo&amp;blueprint=4014254",
      "text": "Is GALD undervalued compared to its fair value, analyst forecasts and its price relative to the market?\nValuation Score\n2/6\nValuation Score 2/6\nBelow Fair Value\nSignificantly Below Fair Value\nPrice-To-Earnings vs Peers\nPrice-To-Earnings vs Industry\nPrice-To-Earnings vs Fair Ratio\nAnalyst Forecast\nShare Price vs Fair Value\nWhat is the Fair Price of GALD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.\nDiscounted Cash Flow\nSimply Wall St\nCHF 241.14\nFair Value\n43.9% undervalued intrinsic discount\n12\nNumber of Analysts\nBelow Fair Value: GALD (CHF135.3) is trading below our estimate of fair value (CHF241.14)\nSignificantly Below Fair Value: GALD is trading below fair value by more than 20%.\nKey Valuation Metric\nWhich metric is best to use when looking at relative valuation for GALD?\nKey metric: As GALD is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.\nThe above table shows the Price to Earnings ratio for GALD. This is calculated by dividing GALD's market cap by their current\nearnings.\nWhat is GALD's PE Ratio?\nPE Ratio\n106.1x\nEarnings\nUS$378.00m\nMarket Cap\nUS$40.09b\nGALD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.\nPrice-To-Earnings vs Industry: GALD is expensive based on its Price-To-Earnings Ratio (106.1x) compared to the European Pharmaceuticals industry average (21.1x).\nPrice to Earnings Ratio vs Fair Ratio\nWhat is GALD's PE Ratio\ncompared to its\nFair PE Ratio?\nThis is the expected PE Ratio taking into\naccount the company's forecast earnings growth, profit margins\nand other risk factors.\nGALD PE Ratio vs Fair Ratio.\nFair Ratio\nCurrent PE Ratio\n106.1x\nFair PE Ratio\n45.4x\nPrice-To-Earnings vs Fair Ratio: GALD is expensive based on its Price-To-Earnings Ratio (106.1x) compared to the estimated Fair Price-To-Earnings Ratio (45.4x).\nAnalyst Price Targets\nWhat is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?\nThe above table shows the analyst GALD forecast and predictions for the stock price in 12 month\u2019s time.\nDate\nShare Price\nAverage 1Y Price Target\nDispersion\nHigh\nLow\n1Y Actual price\nAnalysts\nCurrent\nCHF 135.30\nCHF 140.69\n+3.99%\n12.98%\nCHF 164.30\nCHF 93.29\nn/a\n12\nAug \u201926\nCHF 127.50\nCHF 136.93\n+7.39%\n13.74%\nCHF 164.50\nCHF 93.40\nn/a\n12\nJul \u201926\nCHF 115.50\nCHF 110.41\n-4.41%\n11.63%\nCHF 129.98\nCHF 82.32\nn/a\n11\nJun \u201926\nCHF 107.70\nCHF 107.67\n-0.024%\n8.26%\nCHF 119.40\nCHF 85.47\nn/a\n11\nMay \u201926\nCHF 95.90\nCHF 107.36\n+11.95%\n7.91%\nCHF 115.57\nCHF 85.62\nn/a\n11\nApr \u201926\nCHF 95.43\nCHF 112.07\n+17.44%\n9.10%\nCHF 123.94\nCHF 85.93\nn/a\n11\nMar \u201926\nCHF 109.94\nCHF 108.76\n-1.07%\n11.00%\nCHF 128.06\nCHF 87.90\nn/a\n11\nFeb \u201926\nCHF 110.70\nCHF 103.53\n-6.48%\n10.58%\nCHF 123.81\nCHF 84.51\nn/a\n11\nJan \u201926\nCHF 100.64\nCHF 99.84\n-0.79%\n7.85%\nCHF 109.53\nCHF 83.57\nn/a\n11\nDec \u201925\nCHF 90.25\nCHF 93.20\n+3.27%\n7.45%\nCHF 107.33\nCHF 80.47\nn/a\n11\nNov \u201925\nCHF 81.44\nCHF 89.47\n+9.86%\n7.90%\nCHF 105.52\nCHF 79.12\nn/a\n11\nOct \u201925\nCHF 77.61\nCHF 82.53\n+6.33%\n9.50%\nCHF 102.40\nCHF 72.86\nn/a\n11\nSep \u201925\nCHF 82.30\nCHF 80.01\n-2.79%\n7.59%\nCHF 90.14\nCHF 70.34\nn/a\n10\nAug \u201925\nCHF 69.09\nCHF 77.33\n+11.93%\n5.05%\nCHF 82.41\nCHF 71.02\nCHF 127.50\n8\nJul \u201925\nCHF 72.11\nCHF 78.81\n+9.30%\n4.64%\nCHF 83.81\nCHF 71.25\nCHF 115.50\n8\nJun \u201925\nCHF 73.27\nCHF 78.29\n+6.85%\n4.08%\nCHF 81.95\nCHF 71.96\nCHF 107.70\n7\nAnalystConsensusTarget\nConsensus Narrative from 12 Analysts\nCHF 140.69\nFair Value\n3.8% undervalued intrinsic discount\n12\nNumber of Analysts\nAnalyst Forecast: Target price is less than 20% higher than the current share price.\nDiscover undervalued companies\n7D\n1Y\n7D\n1Y\n7D\n1Y\nCompany Analysis and Financial Data Status\nData\nLast Updated (UTC time)\nCompany Analysis\n2025/08/25 03:22\nEnd of Day Share Price\n2025/08/22 00:00\nEarnings\n2025/06/30\nAnnual Earnings\n2024/12/31\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nGalderma Group AG is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    },
    {
      "url": "https://simplywall.st/news/european-market-highlights-3-stocks-estimated-below-intrinsi-1?blueprint=4014254&utm_source=yahoo&utm_medium=finance_user&utm_campaign=integrated-pitch",
      "text": "European Market Highlights 3 Stocks Estimated Below Intrinsic Value\nReviewed by Simply Wall St\nIn recent weeks, European markets have shown resilience, with the STOXX Europe 600 Index climbing 1.40%, driven by optimism around potential rate cuts in the U.S. and a rebound in eurozone business activity. Amidst this positive momentum, identifying stocks that are trading below their intrinsic value can be crucial for investors seeking opportunities to capitalize on market inefficiencies.\nTop 10 Undervalued Stocks Based On Cash Flows In Europe\n| Name | Current Price | Fair Value (Est) | Discount (Est) |\n| Robit Oyj (HLSE:ROBIT) | \u20ac1.16 | \u20ac2.26 | 48.8% |\n| Norconsult (OB:NORCO) | NOK45.80 | NOK90.81 | 49.6% |\n| innoscripta (XTRA:1INN) | \u20ac101.60 | \u20ac197.30 | 48.5% |\n| Honkarakenne Oyj (HLSE:HONBS) | \u20ac2.87 | \u20ac5.60 | 48.8% |\n| Digital Workforce Services Oyj (HLSE:DWF) | \u20ac3.57 | \u20ac6.91 | 48.3% |\n| ATON Green Storage (BIT:ATON) | \u20ac2.08 | \u20ac4.09 | 49.2% |\n| Atea (OB:ATEA) | NOK146.20 | NOK285.00 | 48.7% |\n| Aquila Part Prod Com (BVB:AQ) | RON1.458 | RON2.85 | 48.8% |\n| Apotea (OM:APOTEA) | SEK107.22 | SEK209.15 | 48.7% |\n| ABO Energy GmbH KGaA (XTRA:AB9) | \u20ac36.60 | \u20ac71.71 | 49% |\nLet's take a closer look at a couple of our picks from the screened companies.\nPandora (CPSE:PNDORA)\nOverview: Pandora A/S designs, manufactures, and markets jewelry products with a market cap of DKK69.67 billion.\nOperations: The company's revenue segments include Core, generating DKK24.03 billion, and Segment Adjustment, contributing DKK8.47 billion.\nEstimated Discount To Fair Value: 35.6%\nPandora A/S is trading at DKK 912, significantly below its estimated fair value of DKK 1,416.73, indicating potential undervaluation based on cash flows. Despite a high debt level and volatile share price recently, Pandora's earnings are projected to grow at 7.9% annually, outpacing the Danish market's forecasted growth rate of 4.6%. Recent Q2 results showed increased sales and net income compared to last year, supporting its robust cash flow generation capabilities amidst reaffirmed guidance for organic growth in fiscal year 2025.\n- Our earnings growth report unveils the potential for significant increases in Pandora's future results.\n- Take a closer look at Pandora's balance sheet health here in our report.\nStora Enso Oyj (HLSE:STERV)\nOverview: Stora Enso Oyj is a company that offers renewable solutions for the packaging, biomaterials, wooden constructions, and paper industries both in Finland and globally, with a market cap of \u20ac8.28 billion.\nOperations: The company's revenue is primarily derived from its Packaging Materials segment (\u20ac4.58 billion), followed by Forest (\u20ac3.15 billion), Wood Products (\u20ac1.67 billion), Biomaterials (\u20ac1.57 billion), and Packaging Solutions (\u20ac1.02 billion).\nEstimated Discount To Fair Value: 34.1%\nStora Enso Oyj, trading at \u20ac10.45, is undervalued based on discounted cash flow analysis with an estimated fair value of \u20ac15.84. Despite a volatile share price and low forecasted return on equity of 6.2%, the company expects annual profit growth above market averages over the next three years. Recent Q2 results showed increased sales to \u20ac2,426 million but decreased net income compared to last year, while strategic reviews aim to unlock further value from its Swedish forest assets and core packaging business.\n- In light of our recent growth report, it seems possible that Stora Enso Oyj's financial performance will exceed current levels.\n- Get an in-depth perspective on Stora Enso Oyj's balance sheet by reading our health report here.\nGalderma Group (SWX:GALD)\nOverview: Galderma Group AG is a global dermatology company with a market capitalization of CHF32.12 billion.\nOperations: Galderma Group AG generates revenue primarily from its dermatology segment, amounting to $4.69 billion.\nEstimated Discount To Fair Value: 43.9%\nGalderma Group AG, trading at CHF135.3, is valued below its estimated fair value of CHF241.14 based on discounted cash flow analysis. The company recently raised its 2025 earnings guidance, reflecting robust growth in Therapeutic Dermatology and Injectable Aesthetics. Despite a lower forecasted return on equity of 13.1%, Galderma's revenue and earnings are expected to grow significantly faster than the Swiss market over the next three years, driven by strategic product launches and expansion initiatives.\n- Insights from our recent growth report point to a promising forecast for Galderma Group's business outlook.\n- Dive into the specifics of Galderma Group here with our thorough financial health report.\nKey Takeaways\n- Discover the full array of 210 Undervalued European Stocks Based On Cash Flows right here.\n- Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.\n- Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.\nSearching for a Fresh Perspective?\n- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.\n- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.\n- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.\nThis article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nNew: Manage All Your Stock Portfolios in One Place\nWe've created the ultimate portfolio companion for stock investors, and it's free.\n\u2022 Connect an unlimited number of Portfolios and see your total in one currency\n\u2022 Be alerted to new Warning Signs or Risks via email or mobile\n\u2022 Track the Fair Value of your stocks\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com\nAbout CPSE:PNDORA\nPandora\nEngages in the designing, manufacturing, and marketing of jewelry products.\nUndervalued with reasonable growth potential and pays a dividend."
    },
    {
      "url": "https://simplywall.st/company/id/8a3231f1-711a-49d1-9395-90e1fe76139e?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014254",
      "text": "Pandora (PNDORA) Stock Overview\nEngages in the designing, manufacturing, and marketing of jewelry products. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 5/6 |\n| Future Growth | 4/6 |\n| Past Performance | 4/6 |\n| Financial Health | 2/6 |\n| Dividends | 4/6 |\nRewards\nRisk Analysis\nPNDORA Community Fair Values\nSee what 34 others think this stock is worth. Follow their fair value or set your own to get alerts.\nPandora A/S Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | DKK 912.00 |\n| 52 Week High | DKK 1,415.00 |\n| 52 Week Low | DKK 805.40 |\n| Beta | 1.57 |\n| 1 Month Change | -13.72% |\n| 3 Month Change | -24.16% |\n| 1 Year Change | -20.24% |\n| 3 Year Change | 104.81% |\n| 5 Year Change | 103.25% |\n| Change since IPO | 246.77% |\nRecent News & Updates\nWhat Does Pandora A/S's (CPH:PNDORA) Share Price Indicate?\nJul 29Pandora (CPH:PNDORA) Looks To Prolong Its Impressive Returns\nJul 16Recent updates\nWhat Does Pandora A/S's (CPH:PNDORA) Share Price Indicate?\nJul 29Pandora (CPH:PNDORA) Looks To Prolong Its Impressive Returns\nJul 16Pandora (CPH:PNDORA) Seems To Use Debt Quite Sensibly\nJul 04A Look At The Intrinsic Value Of Pandora A/S (CPH:PNDORA)\nJun 22Does Pandora (CPH:PNDORA) Deserve A Spot On Your Watchlist?\nMay 29Subdued Growth No Barrier To Pandora A/S (CPH:PNDORA) With Shares Advancing 30%\nMay 17The accessible-luxury jewelry brand Pandora posted 8% same-store sales growth in the U.S. last year.\nU.S. jewelry sales advanced a tepid 1.3% in 2024, driven primarily by price increases as the number of units sold dropped 1.6%, according to industry analyst Edahn Golan of Tenoris.Yet, while AmericanWhen Should You Buy Pandora A/S (CPH:PNDORA)?\nApr 17Why You Should Care About Pandora's (CPH:PNDORA) Strong Returns On Capital\nApr 04Is Pandora A/S (CPH:PNDORA) Trading At A 44% Discount?\nMar 23Pandora's (CPH:PNDORA) Upcoming Dividend Will Be Larger Than Last Year's\nMar 11Getting In Cheap On Pandora A/S (CPH:PNDORA) Might Be Difficult\nMar 02Pandora's (CPH:PNDORA) Solid Earnings Have Been Accounted For Conservatively\nFeb 18Pandora's (CPH:PNDORA) Upcoming Dividend Will Be Larger Than Last Year's\nFeb 10Does Pandora (CPH:PNDORA) Have A Healthy Balance Sheet?\nJan 20Is Pandora A/S (CPH:PNDORA) Potentially Undervalued?\nDec 27Why You Should Care About Pandora's (CPH:PNDORA) Strong Returns On Capital\nDec 03Should You Be Adding Pandora (CPH:PNDORA) To Your Watchlist Today?\nNov 20The Phoenix Strategy Is Elevating Brand Desirability And Driving Revenue Growth\nThe Phoenix strategy is transforming Pandora into a full jewelry brand, boosting brand perception and driving revenue growth through increased store traffic and market expansion.Getting In Cheap On Pandora A/S (CPH:PNDORA) Is Unlikely\nNov 08Pandora A/S' (CPH:PNDORA) Intrinsic Value Is Potentially 87% Above Its Share Price\nOct 27Is Pandora (CPH:PNDORA) A Risky Investment?\nOct 13Is Now An Opportune Moment To Examine Pandora A/S (CPH:PNDORA)?\nSep 16Shareholder Returns\n| PNDORA | DK Luxury | DK Market | |\n|---|---|---|---|\n| 7D | 8.0% | 3.2% | 3.3% |\n| 1Y | -20.2% | -16.6% | -37.1% |\nReturn vs Industry: PNDORA underperformed the Danish Luxury industry which returned -16.6% over the past year.\nReturn vs Market: PNDORA exceeded the Danish Market which returned -37.6% over the past year.\nPrice Volatility\n| PNDORA volatility | |\n|---|---|\n| PNDORA Average Weekly Movement | 6.6% |\n| Luxury Industry Average Movement | 4.4% |\n| Market Average Movement | 4.4% |\n| 10% most volatile stocks in DK Market | 8.6% |\n| 10% least volatile stocks in DK Market | 2.3% |\nStable Share Price: PNDORA's share price has been volatile over the past 3 months compared to the Danish market.\nVolatility Over Time: PNDORA's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Danish stocks.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1982 | 37,000 | Alexander Lacik | www.pandoragroup.com |\nPandora A/S engages in the designing, manufacturing, and marketing of jewelry products. The company operates in two segments, Core and Fuel With More. It offers charms, bracelets, rings, earrings, necklaces, and pendants; and lab-grown diamonds.\nPandora A/S Fundamentals Summary\n| PNDORA fundamental statistics | |\n|---|---|\n| Market cap | DKK 69.67b |\n| Earnings (TTM) | DKK 5.37b |\n| Revenue (TTM) | DKK 32.50b |\nIs PNDORA overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| PNDORA income statement (TTM) | |\n|---|---|\n| Revenue | DKK 32.50b |\n| Cost of Revenue | DKK 6.54b |\n| Gross Profit | DKK 25.95b |\n| Other Expenses | DKK 20.59b |\n| Earnings | DKK 5.37b |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nNov 05, 2025\n| Earnings per share (EPS) | 70.25 |\n| Gross Margin | 79.87% |\n| Net Profit Margin | 16.52% |\n| Debt/Equity Ratio | 303.9% |\nHow did PNDORA perform over the long term?\nSee historical performance and comparisonDividends\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 02:09 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nPandora A/S is covered by 39 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | ABG Sundal Collier |\n| Mariana Horn Uribe | Berenberg |\n| Melania Grippo | BNP Paribas Exane |"
    },
    {
      "url": "https://simplywall.st/features/portfolio?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
      "text": "Test drive a portfolio\nCurious to try a demo portfolio? Test it without signing up.\nOur intuitive tools simplify tracking, provide in-depth analysis, and help you make well-timed decisions to optimize your returns.\nGet a detailed breakdown of your true returns. Add your transactions and unlock:\nEasily consolidate your portfolios from various brokers into a single, intuitive platform. Gain a quick and clear view of your entire investment landscape, reducing time and effort.\nConnect to your broker and import your portfolio within minutes. No need for manual updates.\nStay ahead with important and timely updates for your stocks. We make sure you receive critical and actionable updates for your stocks without the clutter.\nCurious to try a demo portfolio? Test it without signing up.\nOver 7,000,000 investors use Simply Wall St to improve their investing experience.\nGrow your portfolio with all the tools you need."
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/10228/fast-growing-stocks-with-high-insider-ownership/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014254",
      "text": "Results\n1374\nCompanies with strong growth potential, backed by optimistic outlooks both from analysts and management.\n1374 companies\nFulin Precision\nMarket Cap: CN\u00a526.5b\nEngages in the research and development, manufacture, and sale of automotive engine parts in China.\n300432\nCN\u00a515.51\n7D\n-1.1%\n1Y\n235.6%\nSynspective\nMarket Cap: JP\u00a594.5b\nDesigns, builds, and operates a fleet of synthetic aperture radar satellites (SAR) to detect and understand changes.\n290A\nJP\u00a5847.00\n7D\n-12.8%\n1Y\nn/a\nGold Circuit Electronics\nMarket Cap: NT$223.4b\nDesigns, manufactures, processes, and distributes printed circuit boards in Taiwan.\n2368\nNT$459.00\n7D\n-1.4%\n1Y\n112.5%\nFindi\nMarket Cap: AU$239.2m\nThrough its subsidiaries, engages in the development of digital payment systems in India.\nFND\nAU$3.87\n7D\n-3.5%\n1Y\n-5.1%\nNovoray\nMarket Cap: CN\u00a514.6b\nProvides industrial powder materials for various applications in China and internationally.\n688300\nCN\u00a560.54\n7D\n3.6%\n1Y\n92.9%\nLaopu Gold\nMarket Cap: HK$125.8b\nDesigns, manufactures, and sells jewelry products in Mainland China, Hong Kong, and Macau.\n6181\nHK$728.50\n7D\n-6.6%\n1Y\n686.7%\nCyclopharm\nMarket Cap: AU$108.9m\nCyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.\nCYC\nAU$0.98\n7D\n-5.8%\n1Y\n-30.2%\nElliptic Laboratories\nMarket Cap: NOK 1.2b\nAn artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan.\nELABS\nNOK 11.06\n7D\n-7.8%\n1Y\n-10.7%\nPharma Mar\nMarket Cap: \u20ac1.4b\nA biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.\nPHM\n\u20ac82.45\n7D\n-2.5%\n1Y\n101.7%\nAscentage Pharma Group International\nMarket Cap: HK$33.7b\nA clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.\n6855\nHK$90.65\n7D\n5.3%\n1Y\n215.9%\nCredo Technology Group Holding\nMarket Cap: US$19.6b\nProvides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.\nCRDO\nUS$114.04\n7D\n-4.0%\n1Y\n223.9%\nPropel Holdings\nMarket Cap: CA$1.3b\nOperates as a financial technology company.\nPRL\nCA$32.76\n7D\n-0.06%\n1Y\n17.4%\nCD Projekt\nMarket Cap: z\u014225.8b\nTogether its subsidiaries, engages in the development, publishing, and digital distribution of video games for personal computers and video game consoles in Poland.\nCDR\nz\u0142257.90\n7D\n1.1%\n1Y\n43.1%\nKebNi\nMarket Cap: SEK 688.7m\nDevelops, produces, and sells products and applications for stabilization, navigation, and satcom worldwide.\nKEBNI B\nSEK 2.54\n7D\n17.1%\n1Y\n76.6%\nHesai Group\nMarket Cap: US$3.1b\nThrough with its subsidiaries, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally.\nHSAI\nUS$23.26\n7D\n-9.1%\n1Y\n445.4%\nNewfield Resources\nMarket Cap: AU$83.7m\nEngages in the mine development, stope mining, and mineral exploration activities in Australia and Africa.\nNWF\nAU$0.089\n7D\n0%\n1Y\n-19.1%\nM31 Technology\nMarket Cap: NT$19.7b\nProvides silicon intellectual property (IP) design services in the integrated circuit industry.\n6643\nNT$472.50\n7D\n-5.9%\n1Y\n-53.2%\nImage Resources\nMarket Cap: AU$88.1m\nEngages in the production and exploration of mineral sands in Western Australia.\nIMA\nAU$0.079\n7D\n0%\n1Y\n8.2%\nVuno\nMarket Cap: \u20a9291.9b\nOperates as a medical artificial intelligence (AI) solution development company.\nA338220\n\u20a920,850.00\n7D\n4.0%\n1Y\n-44.4%\nAprilBioLtd\nMarket Cap: \u20a9474.2b\nAprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.\nA397030\n\u20a921,050.00\n7D\n-2.3%\n1Y\n1.7%\nSuzhou Sunmun Technology\nMarket Cap: CN\u00a54.6b\nEngages in the research, production, and sale of nano-coloring materials, functional nano-dispersions, special additives, intelligent color matching systems, and electronic chemicals in China.\n300522\nCN\u00a514.24\n7D\n-0.8%\n1Y\n54.4%\nKrishna Institute of Medical Sciences\nMarket Cap: \u20b9294.8b\nProvides medical and health care services under the KIMS Hospitals brand in India.\nKIMS\n\u20b9736.80\n7D\n-1.1%\n1Y\n49.1%\nAnand Rathi Wealth\nMarket Cap: \u20b9233.0b\nProvides financial advisory, brokerage, and consultancy services in India.\nANANDRATHI\n\u20b92,806.20\n7D\n3.5%\n1Y\n55.7%\nFenix Resources\nMarket Cap: AU$227.0m\nEngages in the exploration, development, and mining of mineral tenements in Western Australia.\nFEX\nAU$0.30\n7D\n-7.6%\n1Y\n0%\nOscotec\nMarket Cap: \u20a91.2t\nOperates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.\nA039200\n\u20a932,600.00\n7D\n-5.5%\n1Y\n-18.4%\nZhejiang Leapmotor Technology\nMarket Cap: HK$99.9b\nEngages in the research and development, production, and sale of new energy vehicles in Mainland China and internationally.\n9863\nHK$71.00\n7D\n8.6%\n1Y\n249.8%\nHippo Holdings\nMarket Cap: US$844.7m\nProvides property and casualty insurance products to individuals and business customers primarily in the United States.\nHIPO\nUS$33.75\n7D\n6.7%\n1Y\n70.0%\nTechwing\nMarket Cap: \u20a91.0t\nDevelops, manufactures, sells, and services semiconductor inspection equipment in South Korea and internationally.\nA089030\n\u20a928,850.00\n7D\n-1.2%\n1Y\n-37.1%\nBinastra Corporation Berhad\nMarket Cap: RM 1.9b\nAn investment holding company, engages in general contractor and property developer, building and civil engineering works in turnkey projects in Malaysia.\nBNASTRA\nRM 1.78\n7D\n0.6%\n1Y\n44.7%\nSineng ElectricLtd\nMarket Cap: CN\u00a512.3b\nEngages in the research and development, manufacture, maintenance, and trading of power electronic products in the People's Republic of China and internationally.\n300827\nCN\u00a524.59\n7D\n-0.04%\n1Y\n12.2%\nSamyang Foods\nMarket Cap: \u20a910.7t\nEngages in the food business in South Korea and internationally.\nA003230\n\u20a91,438,000.00\n7D\n4.2%\n1Y\n187.6%\nMarinomed Biotech\nMarket Cap: \u20ac35.2m\nA biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.\nMARI\n\u20ac19.80\n7D\n1.0%\n1Y\n253.6%\nBergen Carbon Solutions\nMarket Cap: NOK 187.6m\nOperates as a clean carbon technology and materials company in Norway.\nBCS\nNOK 4.47\n7D\n-6.7%\n1Y\n-12.4%\nENGAGE XR Holdings\nMarket Cap: UK\u00a35.4m\nEngages in the development of the educational virtual reality platform.\nEXR\nUK\u00a30.01\n7D\n0%\n1Y\n17.1%\nCircus\nMarket Cap: \u20ac402.0m\nA technology company, develops and delivers autonomous solutions for the food service market.\nCA1\n\u20ac16.90\n7D\n-12.7%\n1Y\n-21.8%\nAtour Lifestyle Holdings\nMarket Cap: US$4.9b\nThrough its subsidiaries, develops lifestyle brands around hotel offerings in the People\u2019s Republic of China.\nATAT\nUS$35.73\n7D\n2.4%\n1Y\n103.9%"
    },
    {
      "url": "https://simplywall.st/company/id/8a3231f1-711a-49d1-9395-90e1fe76139e/health?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
      "text": "Pandora Balance Sheet Health\nFinancial Health criteria checks 2/6\nPandora has a total shareholder equity of DKK3.6B and total debt of DKK10.8B, which brings its debt-to-equity ratio to 303.9%. Its total assets and total liabilities are DKK27.0B and DKK23.5B respectively. Pandora's EBIT is DKK8.1B making its interest coverage ratio 11.3. It has cash and short-term investments of DKK817.0M.\nKey information\n303.86%\nDebt to equity ratio\nDKK 10.79b\nDebt\n| Interest coverage ratio | 11.3x |\n| Cash | DKK 817.00m |\n| Equity | DKK 3.55b |\n| Total liabilities | DKK 23.46b |\n| Total assets | DKK 27.01b |\nRecent financial health updates\nPandora (CPH:PNDORA) Seems To Use Debt Quite Sensibly\nJul 04Does Pandora (CPH:PNDORA) Have A Healthy Balance Sheet?\nJan 20Is Pandora (CPH:PNDORA) A Risky Investment?\nOct 13Recent updates\nWhat Does Pandora A/S's (CPH:PNDORA) Share Price Indicate?\nJul 29Pandora (CPH:PNDORA) Looks To Prolong Its Impressive Returns\nJul 16Pandora (CPH:PNDORA) Seems To Use Debt Quite Sensibly\nJul 04A Look At The Intrinsic Value Of Pandora A/S (CPH:PNDORA)\nJun 22Does Pandora (CPH:PNDORA) Deserve A Spot On Your Watchlist?\nMay 29Subdued Growth No Barrier To Pandora A/S (CPH:PNDORA) With Shares Advancing 30%\nMay 17The accessible-luxury jewelry brand Pandora posted 8% same-store sales growth in the U.S. last year.\nU.S. jewelry sales advanced a tepid 1.3% in 2024, driven primarily by price increases as the number of units sold dropped 1.6%, according to industry analyst Edahn Golan of Tenoris.Yet, while AmericanWhen Should You Buy Pandora A/S (CPH:PNDORA)?\nApr 17Why You Should Care About Pandora's (CPH:PNDORA) Strong Returns On Capital\nApr 04Is Pandora A/S (CPH:PNDORA) Trading At A 44% Discount?\nMar 23Pandora's (CPH:PNDORA) Upcoming Dividend Will Be Larger Than Last Year's\nMar 11Getting In Cheap On Pandora A/S (CPH:PNDORA) Might Be Difficult\nMar 02Pandora's (CPH:PNDORA) Solid Earnings Have Been Accounted For Conservatively\nFeb 18Pandora's (CPH:PNDORA) Upcoming Dividend Will Be Larger Than Last Year's\nFeb 10Does Pandora (CPH:PNDORA) Have A Healthy Balance Sheet?\nJan 20Is Pandora A/S (CPH:PNDORA) Potentially Undervalued?\nDec 27Why You Should Care About Pandora's (CPH:PNDORA) Strong Returns On Capital\nDec 03Should You Be Adding Pandora (CPH:PNDORA) To Your Watchlist Today?\nNov 20The Phoenix Strategy Is Elevating Brand Desirability And Driving Revenue Growth\nThe Phoenix strategy is transforming Pandora into a full jewelry brand, boosting brand perception and driving revenue growth through increased store traffic and market expansion.Getting In Cheap On Pandora A/S (CPH:PNDORA) Is Unlikely\nNov 08Pandora A/S' (CPH:PNDORA) Intrinsic Value Is Potentially 87% Above Its Share Price\nOct 27Is Pandora (CPH:PNDORA) A Risky Investment?\nOct 13Is Now An Opportune Moment To Examine Pandora A/S (CPH:PNDORA)?\nSep 16Financial Position Analysis\nShort Term Liabilities: PNDORA's short term assets (DKK8.1B) do not cover its short term liabilities (DKK10.9B).\nLong Term Liabilities: PNDORA's short term assets (DKK8.1B) do not cover its long term liabilities (DKK12.6B).\nDebt to Equity History and Analysis\nDebt Level: PNDORA's net debt to equity ratio (280.8%) is considered high.\nReducing Debt: PNDORA's debt to equity ratio has increased from 90.8% to 303.9% over the past 5 years.\nDebt Coverage: PNDORA's debt is well covered by operating cash flow (74.2%).\nInterest Coverage: PNDORA's interest payments on its debt are well covered by EBIT (11.3x coverage).\nBalance Sheet\nDiscover healthy companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 02:09 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nPandora A/S is covered by 39 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | ABG Sundal Collier |\n| Mariana Horn Uribe | Berenberg |\n| Melania Grippo | BNP Paribas Exane |"
    },
    {
      "url": "https://simplywall.st/company/id/98563a56-5181-46a8-9916-346a18ef6bfa/future?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
      "text": "Stora Enso Oyj Future Growth\nFuture criteria checks 4/6\nStora Enso Oyj is forecast to grow earnings and revenue by 43.4% and 4.1% per annum respectively. EPS is expected to grow by 56.5% per annum. Return on equity is forecast to be 6.2% in 3 years.\nKey information\n43.4%\nEarnings growth rate\n56.47%\nEPS growth rate\n| Forestry earnings growth | 24.1% |\n| Revenue growth rate | 4.1% |\n| Future return on equity | 6.17% |\n| Analyst coverage | Good |\n| Last updated | 14 Aug 2025 |\nRecent future growth updates\nRecent updates\nStora Enso Oyj (HEL:STERV) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing\nApr 08Are Investors Undervaluing Stora Enso Oyj (HEL:STERV) By 31%?\nApr 05Stora Enso Oyj's (HEL:STERV) Upcoming Dividend Will Be Larger Than Last Year's\nMar 18Returns On Capital Signal Tricky Times Ahead For Stora Enso Oyj (HEL:STERV)\nJan 28Investors Continue Waiting On Sidelines For Stora Enso Oyj (HEL:STERV)\nDec 19Enso's Profit Improvement And Strategic Moves Set To Boost Earnings And Market Competitiveness\nThe focus on sustainability and efficiency at the Beihai site could enhance market competitiveness and boost net margins.Is Stora Enso Oyj (HEL:STERV) Using Too Much Debt?\nSep 19Stora Enso Oyj (HEL:STERV) May Have Issues Allocating Its Capital\nSep 01Earnings and Revenue Growth Forecasts\n| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |\n|---|---|---|---|---|---|\n| 12/31/2027 | 10,512 | 641 | 595 | 1,255 | 11 |\n| 12/31/2026 | 10,130 | 502 | 453 | 1,122 | 13 |\n| 12/31/2025 | 9,553 | 249 | 171 | 768 | 12 |\n| 6/30/2025 | 9,372 | -116 | -205 | 718 | N/A |\n| 3/31/2025 | 9,247 | -102 | -82 | 897 | N/A |\n| 12/31/2024 | 9,049 | -136 | -161 | 952 | N/A |\n| 9/30/2024 | 8,901 | -82 | -231 | 974 | N/A |\n| 6/30/2024 | 8,767 | -203 | -171 | 960 | N/A |\n| 3/31/2024 | 8,839 | -467 | -341 | 768 | N/A |\n| 12/31/2023 | 9,396 | -357 | -237 | 752 | N/A |\n| 9/30/2023 | 10,086 | 516 | -61 | 824 | N/A |\n| 6/30/2023 | 10,923 | 921 | 349 | 1,191 | N/A |\n| 3/31/2023 | 11,603 | 1,450 | 673 | 1,453 | N/A |\n| 12/31/2022 | 11,680 | 1,550 | 878 | 1,582 | N/A |\n| 9/30/2022 | 11,535 | 1,580 | 1,078 | 1,750 | N/A |\n| 6/30/2022 | 11,148 | 1,509 | 955 | 1,615 | N/A |\n| 3/31/2022 | 10,686 | 1,411 | 1,034 | 1,663 | N/A |\n| 12/31/2021 | 10,164 | 1,266 | 832 | 1,476 | N/A |\n| 9/30/2021 | 9,598 | 889 | 657 | 1,322 | N/A |\n| 6/30/2021 | 9,100 | 676 | 593 | 1,267 | N/A |\n| 3/31/2021 | 8,622 | 618 | 513 | 1,189 | N/A |\n| 12/31/2020 | 8,553 | 626 | 467 | 1,128 | N/A |\n| 9/30/2020 | 8,811 | 907 | 736 | 1,391 | N/A |\n| 6/30/2020 | 9,134 | 888 | 779 | 1,433 | N/A |\n| 3/31/2020 | 9,627 | 800 | 955 | 1,607 | N/A |\n| 12/31/2019 | 10,055 | 880 | 1,062 | 1,660 | N/A |\n| 9/30/2019 | 10,302 | 664 | 742 | 1,288 | N/A |\n| 6/30/2019 | 10,485 | 809 | 741 | 1,270 | N/A |\n| 3/31/2019 | 10,542 | 971 | N/A | 1,090 | N/A |\n| 12/31/2018 | 10,486 | 1,013 | N/A | 1,092 | N/A |\n| 9/30/2018 | 10,339 | 883 | N/A | 1,291 | N/A |\n| 6/30/2018 | 10,263 | 860 | N/A | 1,247 | N/A |\n| 3/31/2018 | 10,127 | 785 | N/A | 1,245 | N/A |\n| 12/31/2017 | 10,045 | 625 | N/A | 1,202 | N/A |\n| 9/30/2017 | 9,930 | 542 | N/A | 1,147 | N/A |\n| 6/30/2017 | 9,844 | 480 | N/A | 1,115 | N/A |\n| 3/31/2017 | 9,876 | 459 | N/A | 1,272 | N/A |\n| 12/31/2016 | 9,854 | 463 | N/A | 1,360 | N/A |\n| 9/30/2016 | 9,999 | 796 | N/A | 1,295 | N/A |\n| 6/30/2016 | 10,076 | 791 | N/A | 1,356 | N/A |\n| 3/31/2016 | 10,078 | 796 | N/A | 1,335 | N/A |\n| 12/31/2015 | 10,094 | 807 | N/A | 1,216 | N/A |\n| 9/30/2015 | 10,144 | 258 | N/A | 1,226 | N/A |\n| 6/30/2015 | 10,158 | 258 | N/A | 1,021 | N/A |\n| 3/31/2015 | 10,175 | 129 | N/A | 873 | N/A |\n| 12/31/2014 | 10,252 | 99 | N/A | 888 | N/A |\n| 9/30/2014 | 10,317 | 87 | N/A | 918 | N/A |\nAnalyst Future Growth Forecasts\nEarnings vs Savings Rate: STERV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).\nEarnings vs Market: STERV is forecast to become profitable over the next 3 years, which is considered above average market growth.\nHigh Growth Earnings: STERV is expected to become profitable in the next 3 years.\nRevenue vs Market: STERV's revenue (4.1% per year) is forecast to grow faster than the Finnish market (3.9% per year).\nHigh Growth Revenue: STERV's revenue (4.1% per year) is forecast to grow slower than 20% per year.\nEarnings per Share Growth Forecasts\nFuture Return on Equity\nFuture ROE: STERV's Return on Equity is forecast to be low in 3 years time (6.2%).\nDiscover growth companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 04:19 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nStora Enso Oyj is covered by 36 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | ABG Sundal Collier |\n| Varun Sikka | AlphaValue |\n| Pierre-Yves Gauthier | AlphaValue |"
    },
    {
      "url": "https://simplywall.st/company/id/142929bc-161d-4d6b-8d07-8adf129ab8b9/future?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
      "text": "Galderma Group Future Growth\nFuture criteria checks 4/6\nGalderma Group is forecast to grow earnings and revenue by 32% and 13.1% per annum respectively. EPS is expected to grow by 32.3% per annum. Return on equity is forecast to be 13.1% in 3 years.\nKey information\n32.0%\nEarnings growth rate\n32.33%\nEPS growth rate\n| Pharmaceuticals earnings growth | 13.1% |\n| Revenue growth rate | 13.1% |\n| Future return on equity | 13.05% |\n| Analyst coverage | Good |\n| Last updated | 19 Aug 2025 |\nRecent future growth updates\nRecent updates\nIs Galderma Group (VTX:GALD) A Risky Investment?\nAug 24Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%\nMay 20Nemluvio Launch And Global Expansion Will Shape Therapeutic Dermatology Markets\nLaunch of Nemluvio and international expansion in China and India are expected to significantly boost revenue growth and market share.The Price Is Right For Galderma Group AG (VTX:GALD) Even After Diving 27%\nApr 05Galderma Group AG Just Beat EPS By 26%: Here's What Analysts Think Will Happen Next\nMar 08Is There An Opportunity With Galderma Group AG's (VTX:GALD) 50% Undervaluation?\nDec 18These 4 Measures Indicate That Galderma Group (VTX:GALD) Is Using Debt Reasonably Well\nOct 27Earnings and Revenue Growth Forecasts\n| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |\n|---|---|---|---|---|---|\n| 12/31/2027 | 6,776 | 1,152 | 1,129 | 1,602 | 10 |\n| 12/31/2026 | 5,873 | 811 | 754 | 1,192 | 11 |\n| 12/31/2025 | 5,076 | 469 | 529 | 855 | 10 |\n| 6/30/2025 | 4,690 | 378 | 733 | 951 | N/A |\n| 3/31/2025 | 4,565 | 305 | 473 | 720 | N/A |\n| 12/31/2024 | 4,440 | 231 | 213 | 488 | N/A |\n| 9/30/2024 | 4,379 | 109 | 181 | 454 | N/A |\n| 6/30/2024 | 4,318 | -14 | 182 | 419 | N/A |\n| 3/31/2024 | 4,218 | -35 | 98 | 292 | N/A |\n| 12/31/2023 | 4,117 | -57 | 13 | 165 | N/A |\n| 12/31/2022 | 3,824 | -97 | -48 | 111 | N/A |\n| 12/31/2021 | 3,445 | -82 | 68 | 196 | N/A |\nAnalyst Future Growth Forecasts\nEarnings vs Savings Rate: GALD's forecast earnings growth (32% per year) is above the savings rate (0.5%).\nEarnings vs Market: GALD's earnings (32% per year) are forecast to grow faster than the Swiss market (11.3% per year).\nHigh Growth Earnings: GALD's earnings are expected to grow significantly over the next 3 years.\nRevenue vs Market: GALD's revenue (13.1% per year) is forecast to grow faster than the Swiss market (4% per year).\nHigh Growth Revenue: GALD's revenue (13.1% per year) is forecast to grow slower than 20% per year.\nEarnings per Share Growth Forecasts\nFuture Return on Equity\nFuture ROE: GALD's Return on Equity is forecast to be low in 3 years time (13.1%).\nDiscover growth companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/25 03:22 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nGalderma Group AG is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Yihan Li | Barclays |\n| Fulvio Cazzol | Berenberg |\n| Bethan Davies | Berenberg |"
    },
    {
      "url": "https://simplywall.st/company/id/98563a56-5181-46a8-9916-346a18ef6bfa/health?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
      "text": "Stora Enso Oyj Balance Sheet Health\nFinancial Health criteria checks 4/6\nStora Enso Oyj has a total shareholder equity of \u20ac10.0B and total debt of \u20ac5.2B, which brings its debt-to-equity ratio to 52.3%. Its total assets and total liabilities are \u20ac19.7B and \u20ac9.7B respectively. Stora Enso Oyj's EBIT is \u20ac332.0M making its interest coverage ratio 2.7. It has cash and short-term investments of \u20ac1.6B.\nKey information\n52.34%\nDebt to equity ratio\n\u20ac5.21b\nDebt\n| Interest coverage ratio | 2.7x |\n| Cash | \u20ac1.57b |\n| Equity | \u20ac9.95b |\n| Total liabilities | \u20ac9.73b |\n| Total assets | \u20ac19.68b |\nRecent financial health updates\nRecent updates\nStora Enso Oyj (HEL:STERV) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing\nApr 08Are Investors Undervaluing Stora Enso Oyj (HEL:STERV) By 31%?\nApr 05Stora Enso Oyj's (HEL:STERV) Upcoming Dividend Will Be Larger Than Last Year's\nMar 18Returns On Capital Signal Tricky Times Ahead For Stora Enso Oyj (HEL:STERV)\nJan 28Investors Continue Waiting On Sidelines For Stora Enso Oyj (HEL:STERV)\nDec 19Enso's Profit Improvement And Strategic Moves Set To Boost Earnings And Market Competitiveness\nThe focus on sustainability and efficiency at the Beihai site could enhance market competitiveness and boost net margins.Is Stora Enso Oyj (HEL:STERV) Using Too Much Debt?\nSep 19Stora Enso Oyj (HEL:STERV) May Have Issues Allocating Its Capital\nSep 01Financial Position Analysis\nShort Term Liabilities: STERV's short term assets (\u20ac5.4B) exceed its short term liabilities (\u20ac4.4B).\nLong Term Liabilities: STERV's short term assets (\u20ac5.4B) exceed its long term liabilities (\u20ac5.3B).\nDebt to Equity History and Analysis\nDebt Level: STERV's net debt to equity ratio (36.6%) is considered satisfactory.\nReducing Debt: STERV's debt to equity ratio has reduced from 56.1% to 52.3% over the past 5 years.\nDebt Coverage: STERV's debt is not well covered by operating cash flow (13.8%).\nInterest Coverage: STERV's interest payments on its debt are not well covered by EBIT (2.7x coverage).\nBalance Sheet\nDiscover healthy companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 04:19 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nStora Enso Oyj is covered by 36 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | ABG Sundal Collier |\n| Varun Sikka | AlphaValue |\n| Pierre-Yves Gauthier | AlphaValue |"
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/168/undervalued-stocks-based-on-cash-flows/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014254",
      "text": "Results\n860\nCompanies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.\n860 companies\nAmbipar Participa\u00e7\u00f5es e Empreendimentos\nMarket Cap: R$22.3b\nAmbipar Participa\u00e7\u00f5es e Empreendimentos S.A.\nAMBP3\nR$13.40\n7D\n-4.4%\n1Y\n51.9%\nKolmar Korea\nMarket Cap: \u20a91.9t\nResearches, develops, produces, and sells beauty and health products in South Korea and internationally.\nA161890\n\u20a979,100.00\n7D\n-0.8%\n1Y\n12.8%\nWELL Health Technologies\nMarket Cap: CA$1.2b\nOperates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.\nWELL\nCA$4.92\n7D\n-1.6%\n1Y\n6.5%\nBloomberry Resorts\nMarket Cap: \u20b141.0b\nThrough its subsidiaries, develops, owns, and operates hotels, casinos, and integrated resorts in the Philippines and Korea.\nBLOOM\n\u20b13.57\n7D\n-0.8%\n1Y\n-53.6%\nS Chand\nMarket Cap: \u20b97.0b\nS Chand and Company Limited, an education content company, develops and delivers content, solutions, and services for the early learning, K-12, and higher education segments in India.\nSCHAND\n\u20b9197.85\n7D\n1.9%\n1Y\n-14.2%\nWanguo Gold Group\nMarket Cap: HK$32.0b\nAn investment holding company, engages in mining, ore processing, and sale of concentrate products in the People\u2019s Republic of China and Solomon Islands.\n3939\nHK$29.50\n7D\n-16.2%\n1Y\n282.1%\nEROAD\nMarket Cap: NZ$434.0m\nProvides electronic on-board units and software as a service to the transport industry in New Zealand, the United States, and Australia.\nERD\nNZ$2.32\n7D\n0.4%\n1Y\n78.5%\nSavaria\nMarket Cap: CA$1.5b\nProvides accessibility solutions for the elderly and physically challenged people in Canada, the United States, Europe, and internationally.\nSIS\nCA$21.15\n7D\n0.5%\n1Y\n5.6%\nWix.com\nMarket Cap: US$7.4b\nOperates a cloud-based web development platform for registered users and creators worldwide.\nWIX\nUS$131.82\n7D\n2.4%\n1Y\n-20.6%\nKeePer Technical Laboratory\nMarket Cap: JP\u00a594.0b\nDevelops, manufactures, and sells car coatings, car washing chemicals and equipment, and other products in Japan.\n6036\nJP\u00a53,445.00\n7D\n-1.3%\n1Y\n-7.9%\nNorconsult\nMarket Cap: NOK 14.2b\nProvides consultancy services with focus on community planning, engineering design, and architecture in the Nordics and internationally.\nNORCO\nNOK 45.80\n7D\n6.9%\n1Y\n32.9%\nCosmax\nMarket Cap: \u20a92.4t\nResearches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally.\nA192820\n\u20a9213,000.00\n7D\n12.0%\n1Y\n75.5%\nMatsuya R&DLtd\nMarket Cap: JP\u00a515.4b\nDevelops, manufactures, and sells stitching systems for automobile safety devices in Japan.\n7317\nJP\u00a5720.00\n7D\n2.1%\n1Y\n9.4%\nCorporativo Fragua. de\nMarket Cap: Mex$51.3b\nOperates pharmacy stores under the Superfarmacia name in Mexico.\nFRAGUA B\nMex$536.00\n7D\n-0.6%\n1Y\n-48.4%\nUWC Berhad\nMarket Cap: RM 3.0b\nAn investment holding company, engages in the provision of precision sheet metal fabrication, precision machined components, and value-added assembly services.\nUWC\nRM 2.71\n7D\n-1.5%\n1Y\n0.7%\nHillgrove Resources\nMarket Cap: AU$96.7m\nEngages in the operation, exploration, and development of mineral properties in Australia.\nHGO\nAU$0.037\n7D\n5.7%\n1Y\n-33.9%\nInvestar Holding\nMarket Cap: US$230.2m\nOperates as the bank holding company for Investar Bank that provides a range of commercial banking products to individuals, professionals, and small to medium-sized businesses in south Louisiana, southeast Texas, and Alabama in the United States.\nISTR\nUS$23.42\n7D\n6.4%\n1Y\n27.8%\nFaraday Technology\nMarket Cap: NT$38.8b\nOperates as a fabless ASIC/SoC and silicon intellectual property (IP) provider in China, Taiwan, Japan, the United States, and internationally.\n3035\nNT$149.00\n7D\n-2.9%\n1Y\n-49.8%\nJiangxi Rimag Group\nMarket Cap: HK$7.0b\nInvests and operates medical imaging centers in China.\n2522\nHK$19.11\n7D\n-18.0%\n1Y\n5.1%\nSolarEdge Technologies\nMarket Cap: US$2.0b\nDesigns, develops, manufactures, and sells direct current (DC) optimized inverter systems for solar photovoltaic (PV) installations in the United States, Germany, the Netherlands, Italy, rest of Europe, and internationally.\nSEDG\nUS$34.30\n7D\n10.1%\n1Y\n31.3%\nATON Green Storage\nMarket Cap: \u20ac15.6m\nEngages in the production and sale of storage systems for photovoltaic systems and battery energy storage system.\nATON\n\u20ac2.08\n7D\n1.0%\n1Y\n-64.4%\nHypera\nMarket Cap: R$15.0b\nOperates as a pharmaceutical company in Brazil.\nHYPE3\nR$23.75\n7D\n4.1%\n1Y\n-23.5%\nReckon\nMarket Cap: AU$68.5m\nProvides software solutions in Australia, New Zealand, the United States, and internationally.\nRKN\nAU$0.60\n7D\n-4.0%\n1Y\n18.6%\nSunjin Beauty ScienceLtd\nMarket Cap: \u20a9128.1b\nSUNJIN BEAUTY SCIENCE Co. ,Ltd. researches, develops, manufactures, and exports cosmetics, surfactant, and polymer bead products.\nA086710\n\u20a910,670.00\n7D\n-4.4%\n1Y\n-3.8%\nPeapack-Gladstone Financial\nMarket Cap: US$498.5m\nOperates as the bank holding company for Peapack Private Bank & Trust that provides private banking and wealth management services in the United States.\nPGC\nUS$28.46\n7D\n7.2%\n1Y\n1.2%\nABO Energy GmbH KGaA\nMarket Cap: \u20ac337.5m\nDevelops renewable energy projects in Germany and internationally.\nAB9\n\u20ac36.60\n7D\n-4.4%\n1Y\n-21.8%\nMetropolitan Bank Holding\nMarket Cap: US$801.6m\nOperates as the bank holding company for Metropolitan Commercial Bank that provides a range of business, commercial, and retail banking products and services.\nMCB\nUS$76.92\n7D\n5.4%\n1Y\n47.6%\nAquila Part Prod Com\nMarket Cap: RON 1.7b\nProvides distribution and logistics services in Romania, Moldova, Poland, the Netherlands, Germany, and internationally.\nAQ\nRON 1.46\n7D\n1.3%\n1Y\n3.8%\nRobit Oyj\nMarket Cap: \u20ac24.4m\nEngages in the design, manufacture, and sale of drilling consumables for mining, quarrying, construction, and well drilling industries in Finland.\nROBIT\n\u20ac1.16\n7D\n-3.3%\n1Y\n-31.4%\nLATAM Airlines Group\nMarket Cap: CL$13.7t\nProvides passenger and cargo air transportation services in Chile, Argentina, Peru, Colombia, Ecuador, Brazil, the United States, other Latin American countries, the Caribbean, Europe, and Oceania.\nLTM\nCL$23.09\n7D\n9.0%\n1Y\n96.2%\nHonkarakenne Oyj\nMarket Cap: \u20ac16.9m\nDesigns, manufactures, and sells log and solid-wood house packages in Finland.\nHONBS\n\u20ac2.87\n7D\n4.0%\n1Y\n-0.3%\nApotea\nMarket Cap: SEK 11.2b\nOperates an online pharmacy in Sweden.\nAPOTEA\nSEK 107.22\n7D\n-4.1%\n1Y\nn/a\nAtea\nMarket Cap: NOK 16.3b\nProvides IT infrastructure and related solutions for businesses and public sector organizations in the Nordic countries and Baltic regions.\nATEA\nNOK 146.20\n7D\n1.2%\n1Y\n1.4%\nSRE Holdings\nMarket Cap: JP\u00a549.4b\nEngages in the AI cloud and consulting, and real estate tech businesses in Japan.\n2980\nJP\u00a53,070.00\n7D\n-5.4%\n1Y\n-33.0%\nCustomers Bancorp\nMarket Cap: US$2.2b\nOperates as the bank holding company for Customers Bank that provides banking products and services.\nCUBI\nUS$68.72\n7D\n4.3%\n1Y\n34.7%\nAustal\nMarket Cap: AU$2.9b\nEngages in the design, manufacture, and support of vessels for commercial and defense customers worldwide.\nASB\nAU$6.81\n7D\n0.7%\n1Y\n204.0%"
    },
    {
      "url": "https://simplywall.st/company/id/142929bc-161d-4d6b-8d07-8adf129ab8b9/health?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
      "text": "Galderma Group Balance Sheet Health\nFinancial Health criteria checks 4/6\nGalderma Group has a total shareholder equity of $7.7B and total debt of $2.7B, which brings its debt-to-equity ratio to 35.2%. Its total assets and total liabilities are $12.9B and $5.1B respectively. Galderma Group's EBIT is $743.0M making its interest coverage ratio 3.7. It has cash and short-term investments of $458.0M.\nKey information\n35.17%\nDebt to equity ratio\nUS$2.72b\nDebt\n| Interest coverage ratio | 3.7x |\n| Cash | US$458.00m |\n| Equity | US$7.73b |\n| Total liabilities | US$5.15b |\n| Total assets | US$12.88b |\nRecent financial health updates\nIs Galderma Group (VTX:GALD) A Risky Investment?\nAug 24These 4 Measures Indicate That Galderma Group (VTX:GALD) Is Using Debt Reasonably Well\nOct 27Recent updates\nIs Galderma Group (VTX:GALD) A Risky Investment?\nAug 24Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%\nMay 20Nemluvio Launch And Global Expansion Will Shape Therapeutic Dermatology Markets\nLaunch of Nemluvio and international expansion in China and India are expected to significantly boost revenue growth and market share.The Price Is Right For Galderma Group AG (VTX:GALD) Even After Diving 27%\nApr 05Galderma Group AG Just Beat EPS By 26%: Here's What Analysts Think Will Happen Next\nMar 08Is There An Opportunity With Galderma Group AG's (VTX:GALD) 50% Undervaluation?\nDec 18These 4 Measures Indicate That Galderma Group (VTX:GALD) Is Using Debt Reasonably Well\nOct 27Financial Position Analysis\nShort Term Liabilities: GALD's short term assets ($1.9B) exceed its short term liabilities ($1.8B).\nLong Term Liabilities: GALD's short term assets ($1.9B) do not cover its long term liabilities ($3.4B).\nDebt to Equity History and Analysis\nDebt Level: GALD's net debt to equity ratio (29.2%) is considered satisfactory.\nReducing Debt: Insufficient data to determine if GALD's debt to equity ratio has reduced over the past 5 years.\nDebt Coverage: GALD's debt is well covered by operating cash flow (35%).\nInterest Coverage: GALD's interest payments on its debt are well covered by EBIT (3.7x coverage).\nBalance Sheet\nDiscover healthy companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/25 03:22 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nGalderma Group AG is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Yihan Li | Barclays |\n| Fulvio Cazzol | Berenberg |\n| Bethan Davies | Berenberg |"
    },
    {
      "url": "https://simplywall.st/company/id/98563a56-5181-46a8-9916-346a18ef6bfa/valuation?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo&amp;blueprint=4014254",
      "text": "Is STERV undervalued compared to its fair value, analyst forecasts and its price relative to the market?\nValuation Score\n4/6\nValuation Score 4/6\nBelow Fair Value\nSignificantly Below Fair Value\nPrice-To-Sales vs Peers\nPrice-To-Sales vs Industry\nPrice-To-Sales vs Fair Ratio\nAnalyst Forecast\nShare Price vs Fair Value\nWhat is the Fair Price of STERV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.\nDiscounted Cash Flow\nSimply Wall St\n\u20ac15.84\nFair Value\n34.1% undervalued intrinsic discount\n13\nNumber of Analysts\nBelow Fair Value: STERV (\u20ac10.45) is trading below our estimate of fair value (\u20ac15.84)\nSignificantly Below Fair Value: STERV is trading below fair value by more than 20%.\nKey Valuation Metric\nWhich metric is best to use when looking at relative valuation for STERV?\nKey metric: As STERV is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.\nThe above table shows the Price to Sales ratio for STERV. This is calculated by dividing STERV's market cap by their current\nrevenue.\nWhat is STERV's PS Ratio?\nPS Ratio\n0.9x\nSales\n\u20ac9.37b\nMarket Cap\n\u20ac8.28b\nSTERV key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.\nPrice-To-Sales vs Industry: STERV is expensive based on its Price-To-Sales Ratio (0.9x) compared to the European Forestry industry average (0.7x).\nPrice to Sales Ratio vs Fair Ratio\nWhat is STERV's PS Ratio\ncompared to its\nFair PS Ratio?\nThis is the expected PS Ratio taking into\naccount the company's forecast earnings growth, profit margins\nand other risk factors.\nSTERV PS Ratio vs Fair Ratio.\nFair Ratio\nCurrent PS Ratio\n0.9x\nFair PS Ratio\n2.3x\nPrice-To-Sales vs Fair Ratio: STERV is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (2.3x).\nAnalyst Price Targets\nWhat is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?\nThe above table shows the analyst STERV forecast and predictions for the stock price in 12 month\u2019s time.\nDate\nShare Price\nAverage 1Y Price Target\nDispersion\nHigh\nLow\n1Y Actual price\nAnalysts\nCurrent\n\u20ac10.45\n\u20ac11.09\n+6.20%\n13.49%\n\u20ac14.00\n\u20ac8.20\nn/a\n13\nAug \u201926\n\u20ac9.00\n\u20ac10.91\n+21.17%\n15.64%\n\u20ac14.00\n\u20ac8.00\nn/a\n13\nJul \u201926\n\u20ac9.14\n\u20ac10.96\n+19.86%\n17.70%\n\u20ac14.00\n\u20ac8.00\nn/a\n13\nJun \u201926\n\u20ac8.91\n\u20ac11.09\n+24.47%\n16.25%\n\u20ac14.00\n\u20ac8.00\nn/a\n14\nMay \u201926\n\u20ac8.17\n\u20ac11.06\n+35.40%\n17.22%\n\u20ac14.00\n\u20ac7.50\nn/a\n14\nApr \u201926\n\u20ac8.81\n\u20ac12.21\n+38.50%\n10.29%\n\u20ac14.00\n\u20ac10.20\nn/a\n14\nMar \u201926\n\u20ac10.37\n\u20ac12.44\n+20.02%\n12.15%\n\u20ac16.00\n\u20ac10.20\nn/a\n15\nFeb \u201926\n\u20ac10.70\n\u20ac12.80\n+19.68%\n11.92%\n\u20ac16.00\n\u20ac10.00\nn/a\n15\nJan \u201926\n\u20ac9.72\n\u20ac13.11\n+34.90%\n12.88%\n\u20ac17.40\n\u20ac9.80\nn/a\n15\nDec \u201925\n\u20ac9.19\n\u20ac13.28\n+44.51%\n13.86%\n\u20ac17.40\n\u20ac9.80\nn/a\n15\nNov \u201925\n\u20ac10.38\n\u20ac13.65\n+31.50%\n13.16%\n\u20ac17.40\n\u20ac10.00\nn/a\n15\nOct \u201925\n\u20ac11.45\n\u20ac13.89\n+21.39%\n14.20%\n\u20ac16.50\n\u20ac10.00\nn/a\n15\nSep \u201925\n\u20ac11.70\n\u20ac13.84\n+18.32%\n14.68%\n\u20ac17.00\n\u20ac10.00\nn/a\n16\nAug \u201925\n\u20ac11.34\n\u20ac14.09\n+24.28%\n14.33%\n\u20ac17.00\n\u20ac10.30\n\u20ac9.00\n16\nJul \u201925\n\u20ac12.89\n\u20ac13.95\n+8.22%\n15.35%\n\u20ac17.00\n\u20ac9.80\n\u20ac9.14\n14\nJun \u201925\n\u20ac13.41\n\u20ac13.56\n+1.15%\n15.81%\n\u20ac17.00\n\u20ac9.80\n\u20ac8.91\n14\nMay \u201925\n\u20ac12.55\n\u20ac13.32\n+6.15%\n14.27%\n\u20ac16.50\n\u20ac9.80\n\u20ac8.17\n14\nApr \u201925\n\u20ac12.89\n\u20ac12.65\n-1.80%\n14.74%\n\u20ac16.00\n\u20ac9.60\n\u20ac8.81\n14\nMar \u201925\n\u20ac11.79\n\u20ac12.53\n+6.28%\n12.11%\n\u20ac14.50\n\u20ac9.60\n\u20ac10.37\n13\nFeb \u201925\n\u20ac11.25\n\u20ac12.98\n+15.47%\n13.53%\n\u20ac15.20\n\u20ac9.60\n\u20ac10.70\n13\nJan \u201925\n\u20ac12.53\n\u20ac12.92\n+3.12%\n13.30%\n\u20ac15.50\n\u20ac10.00\n\u20ac9.72\n13\nDec \u201924\n\u20ac12.00\n\u20ac12.84\n+7.03%\n13.51%\n\u20ac15.50\n\u20ac10.00\n\u20ac9.19\n13\nNov \u201924\n\u20ac11.32\n\u20ac12.80\n+13.12%\n14.26%\n\u20ac15.50\n\u20ac10.00\n\u20ac10.38\n13\nOct \u201924\n\u20ac11.89\n\u20ac12.48\n+4.94%\n15.83%\n\u20ac15.50\n\u20ac9.70\n\u20ac11.45\n13\nSep \u201924\n\u20ac11.86\n\u20ac12.69\n+7.01%\n15.98%\n\u20ac15.50\n\u20ac9.80\n\u20ac11.70\n14\nAug \u201924\n\u20ac11.21\n\u20ac12.73\n+13.55%\n16.40%\n\u20ac15.90\n\u20ac9.80\n\u20ac11.34\n14\nAnalystConsensusTarget\nConsensus Narrative from 13 Analysts\n\u20ac11.09\nFair Value\n5.8% undervalued intrinsic discount\n13\nNumber of Analysts\nAnalyst Forecast: Target price is less than 20% higher than the current share price.\nDiscover undervalued companies\n7D\n1Y\n7D\n1Y\n7D\n1Y\nCompany Analysis and Financial Data Status\nData\nLast Updated (UTC time)\nCompany Analysis\n2025/08/24 04:19\nEnd of Day Share Price\n2025/08/22 00:00\nEarnings\n2025/06/30\nAnnual Earnings\n2024/12/31\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nStora Enso Oyj is covered by 36 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    },
    {
      "url": "https://simplywall.st/company/id/8a3231f1-711a-49d1-9395-90e1fe76139e/valuation?utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo&amp;blueprint=4014254",
      "text": "Is PNDORA undervalued compared to its fair value, analyst forecasts and its price relative to the market?\nValuation Score\n5/6\nValuation Score 5/6\nBelow Fair Value\nSignificantly Below Fair Value\nPrice-To-Earnings vs Peers\nPrice-To-Earnings vs Industry\nPrice-To-Earnings vs Fair Ratio\nAnalyst Forecast\nShare Price vs Fair Value\nWhat is the Fair Price of PNDORA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.\nDiscounted Cash Flow\nSimply Wall St\nDKK 1.42k\nFair Value\n35.6% undervalued intrinsic discount\n18\nNumber of Analysts\nBelow Fair Value: PNDORA (DKK912) is trading below our estimate of fair value (DKK1416.73)\nSignificantly Below Fair Value: PNDORA is trading below fair value by more than 20%.\nKey Valuation Metric\nWhich metric is best to use when looking at relative valuation for PNDORA?\nKey metric: As PNDORA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.\nThe above table shows the Price to Earnings ratio for PNDORA. This is calculated by dividing PNDORA's market cap by their current\nearnings.\nWhat is PNDORA's PE Ratio?\nPE Ratio\n13x\nEarnings\nDKK 5.37b\nMarket Cap\nDKK 69.67b\nPNDORA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.\nPrice-To-Earnings vs Industry: PNDORA is good value based on its Price-To-Earnings Ratio (13x) compared to the European Luxury industry average (18.9x).\nPrice to Earnings Ratio vs Fair Ratio\nWhat is PNDORA's PE Ratio\ncompared to its\nFair PE Ratio?\nThis is the expected PE Ratio taking into\naccount the company's forecast earnings growth, profit margins\nand other risk factors.\nPNDORA PE Ratio vs Fair Ratio.\nFair Ratio\nCurrent PE Ratio\n13x\nFair PE Ratio\n14.9x\nPrice-To-Earnings vs Fair Ratio: PNDORA is good value based on its Price-To-Earnings Ratio (13x) compared to the estimated Fair Price-To-Earnings Ratio (14.9x).\nAnalyst Price Targets\nWhat is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?\nThe above table shows the analyst PNDORA forecast and predictions for the stock price in 12 month\u2019s time.\nDate\nShare Price\nAverage 1Y Price Target\nDispersion\nHigh\nLow\n1Y Actual price\nAnalysts\nCurrent\nDKK 912.00\nDKK 1,160.28\n+27.22%\n18.27%\nDKK 1,650.00\nDKK 700.00\nn/a\n18\nAug \u201926\nDKK 1,074.50\nDKK 1,204.44\n+12.09%\n17.97%\nDKK 1,650.00\nDKK 700.00\nn/a\n18\nJul \u201926\nDKK 1,108.00\nDKK 1,229.41\n+10.96%\n17.85%\nDKK 1,650.00\nDKK 700.00\nn/a\n17\nJun \u201926\nDKK 1,196.50\nDKK 1,239.17\n+3.57%\n17.27%\nDKK 1,570.00\nDKK 700.00\nn/a\n18\nMay \u201926\nDKK 984.40\nDKK 1,217.19\n+23.65%\n18.07%\nDKK 1,570.00\nDKK 700.00\nn/a\n16\nApr \u201926\nDKK 1,061.00\nDKK 1,355.00\n+27.71%\n14.96%\nDKK 1,700.00\nDKK 1,010.00\nn/a\n15\nMar \u201926\nDKK 1,267.50\nDKK 1,410.67\n+11.30%\n14.99%\nDKK 1,700.00\nDKK 1,010.00\nn/a\n15\nFeb \u201926\nDKK 1,380.50\nDKK 1,329.00\n-3.73%\n13.88%\nDKK 1,550.00\nDKK 1,000.00\nn/a\n15\nJan \u201926\nDKK 1,317.00\nDKK 1,242.20\n-5.68%\n12.03%\nDKK 1,500.00\nDKK 1,000.00\nn/a\n15\nDec \u201925\nDKK 1,136.50\nDKK 1,216.93\n+7.08%\n12.34%\nDKK 1,500.00\nDKK 1,000.00\nn/a\n15\nNov \u201925\nDKK 1,059.50\nDKK 1,235.53\n+16.61%\n12.42%\nDKK 1,470.00\nDKK 1,010.00\nn/a\n15\nOct \u201925\nDKK 1,068.50\nDKK 1,227.60\n+14.89%\n12.98%\nDKK 1,470.00\nDKK 1,010.00\nn/a\n15\nSep \u201925\nDKK 1,181.00\nDKK 1,193.93\n+1.10%\n12.98%\nDKK 1,400.00\nDKK 920.00\nn/a\n15\nAug \u201925\nDKK 1,076.50\nDKK 1,201.93\n+11.65%\n13.12%\nDKK 1,400.00\nDKK 920.00\nDKK 1,074.50\n14\nJul \u201925\nDKK 1,009.00\nDKK 1,211.21\n+20.04%\n11.89%\nDKK 1,400.00\nDKK 1,010.00\nDKK 1,108.00\n14\nJun \u201925\nDKK 1,124.00\nDKK 1,200.07\n+6.77%\n11.18%\nDKK 1,400.00\nDKK 1,010.00\nDKK 1,196.50\n14\nMay \u201925\nDKK 1,082.50\nDKK 1,179.36\n+8.95%\n12.92%\nDKK 1,400.00\nDKK 900.00\nDKK 984.40\n14\nApr \u201925\nDKK 1,114.50\nDKK 1,148.67\n+3.07%\n14.32%\nDKK 1,400.00\nDKK 900.00\nDKK 1,061.00\n15\nMar \u201925\nDKK 1,147.00\nDKK 1,104.81\n-3.68%\n14.81%\nDKK 1,360.00\nDKK 820.00\nDKK 1,267.50\n16\nFeb \u201925\nDKK 999.60\nDKK 989.81\n-0.98%\n12.35%\nDKK 1,200.00\nDKK 720.00\nDKK 1,380.50\n16\nJan \u201925\nDKK 933.20\nDKK 936.31\n+0.33%\n11.46%\nDKK 1,115.00\nDKK 730.00\nDKK 1,317.00\n16\nDec \u201924\nDKK 931.60\nDKK 928.50\n-0.33%\n11.98%\nDKK 1,115.00\nDKK 730.00\nDKK 1,136.50\n16\nNov \u201924\nDKK 814.20\nDKK 851.14\n+4.54%\n13.74%\nDKK 1,000.00\nDKK 630.00\nDKK 1,059.50\n14\nOct \u201924\nDKK 731.60\nDKK 784.21\n+7.19%\n16.21%\nDKK 950.00\nDKK 600.00\nDKK 1,068.50\n14\nSep \u201924\nDKK 714.80\nDKK 739.60\n+3.47%\n15.27%\nDKK 930.00\nDKK 547.00\nDKK 1,181.00\n15\nAug \u201924\nDKK 674.00\nDKK 727.47\n+7.93%\n16.00%\nDKK 930.00\nDKK 540.00\nDKK 1,076.50\n15\nAnalystConsensusTarget\nConsensus Narrative from 18 Analysts\nDKK 1.16k\nFair Value\n21.4% undervalued intrinsic discount\n18\nNumber of Analysts\nAnalyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.\nDiscover undervalued companies\n7D\n1Y\n7D\n1Y\n7D\n1Y\nCompany Analysis and Financial Data Status\nData\nLast Updated (UTC time)\nCompany Analysis\n2025/08/24 02:09\nEnd of Day Share Price\n2025/08/22 00:00\nEarnings\n2025/06/30\nAnnual Earnings\n2024/12/31\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nPandora A/S is covered by 39 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    },
    {
      "url": "https://simplywall.st/company/id/142929bc-161d-4d6b-8d07-8adf129ab8b9?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014254",
      "text": "Galderma Group (GALD) Stock Overview\nOperates as a dermatology company worldwide. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 2/6 |\n| Future Growth | 4/6 |\n| Past Performance | 3/6 |\n| Financial Health | 4/6 |\n| Dividends | 0/6 |\nRewards\nRisk Analysis\nNo risks detected for GALD from our risk checks.\nGALD Community Fair Values\nCreate NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.\nGalderma Group AG Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | CHF 135.30 |\n| 52 Week High | CHF 138.80 |\n| 52 Week Low | CHF 72.70 |\n| Beta | 0 |\n| 1 Month Change | 0.59% |\n| 3 Month Change | 28.98% |\n| 1 Year Change | 64.92% |\n| 3 Year Change | n/a |\n| 5 Year Change | n/a |\n| Change since IPO | 111.41% |\nRecent News & Updates\nRecent updates\nIs Galderma Group (VTX:GALD) A Risky Investment?\nAug 24Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%\nMay 20Nemluvio Launch And Global Expansion Will Shape Therapeutic Dermatology Markets\nLaunch of Nemluvio and international expansion in China and India are expected to significantly boost revenue growth and market share.The Price Is Right For Galderma Group AG (VTX:GALD) Even After Diving 27%\nApr 05Galderma Group AG Just Beat EPS By 26%: Here's What Analysts Think Will Happen Next\nMar 08Is There An Opportunity With Galderma Group AG's (VTX:GALD) 50% Undervaluation?\nDec 18These 4 Measures Indicate That Galderma Group (VTX:GALD) Is Using Debt Reasonably Well\nOct 27Shareholder Returns\n| GALD | CH Pharmaceuticals | CH Market | |\n|---|---|---|---|\n| 7D | 1.2% | 2.4% | 1.6% |\n| 1Y | 64.9% | 0.5% | -0.2% |\nReturn vs Industry: GALD exceeded the Swiss Pharmaceuticals industry which returned 0.5% over the past year.\nReturn vs Market: GALD exceeded the Swiss Market which returned -0.2% over the past year.\nPrice Volatility\n| GALD volatility | |\n|---|---|\n| GALD Average Weekly Movement | 4.2% |\n| Pharmaceuticals Industry Average Movement | 4.7% |\n| Market Average Movement | 3.6% |\n| 10% most volatile stocks in CH Market | 7.7% |\n| 10% least volatile stocks in CH Market | 1.6% |\nStable Share Price: GALD has not had significant price volatility in the past 3 months compared to the Swiss market.\nVolatility Over Time: GALD's weekly volatility (4%) has been stable over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1981 | 6,545 | Flemming Ornskov | www.galderma.com |\nGalderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Actinica, Dysport/Azzalure, Alluzience, Restylane and Restylane Skinboosters, Sculptra, Cetaphil and Alastin, Soolantra, Epiduo and Epiduo Forte, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Mirvaso, Nemluvio, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology.\nGalderma Group AG Fundamentals Summary\n| GALD fundamental statistics | |\n|---|---|\n| Market cap | CHF 32.12b |\n| Earnings (TTM) | CHF 302.88m |\n| Revenue (TTM) | CHF 3.76b |\nIs GALD overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| GALD income statement (TTM) | |\n|---|---|\n| Revenue | US$4.69b |\n| Cost of Revenue | US$1.44b |\n| Gross Profit | US$3.25b |\n| Other Expenses | US$2.87b |\n| Earnings | US$378.00m |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 1.59 |\n| Gross Margin | 69.21% |\n| Net Profit Margin | 8.06% |\n| Debt/Equity Ratio | 35.2% |\nHow did GALD perform over the long term?\nSee historical performance and comparisonDividends\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/25 03:22 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nGalderma Group AG is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| Yihan Li | Barclays |\n| Fulvio Cazzol | Berenberg |\n| Bethan Davies | Berenberg |"
    },
    {
      "url": "https://simplywall.st/company/id/98563a56-5181-46a8-9916-346a18ef6bfa?utm_medium=finance_user&utm_campaign=cta&utm_source=yahoo&blueprint=4014254",
      "text": "Stora Enso Oyj (STERV) Stock Overview\nProvides renewable solutions for the packaging, biomaterials, wooden constructions, and paper industries in Finland and internationally. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 4/6 |\n| Future Growth | 4/6 |\n| Past Performance | 0/6 |\n| Financial Health | 4/6 |\n| Dividends | 1/6 |\nSTERV Community Fair Values\nSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.\nStora Enso Oyj Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | \u20ac10.45 |\n| 52 Week High | \u20ac12.35 |\n| 52 Week Low | \u20ac7.10 |\n| Beta | 0.63 |\n| 1 Month Change | 6.32% |\n| 3 Month Change | 15.75% |\n| 1 Year Change | -9.17% |\n| 3 Year Change | -29.85% |\n| 5 Year Change | -13.78% |\n| Change since IPO | 62.32% |\nRecent News & Updates\nRecent updates\nStora Enso Oyj (HEL:STERV) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing\nApr 08Are Investors Undervaluing Stora Enso Oyj (HEL:STERV) By 31%?\nApr 05Stora Enso Oyj's (HEL:STERV) Upcoming Dividend Will Be Larger Than Last Year's\nMar 18Returns On Capital Signal Tricky Times Ahead For Stora Enso Oyj (HEL:STERV)\nJan 28Investors Continue Waiting On Sidelines For Stora Enso Oyj (HEL:STERV)\nDec 19Enso's Profit Improvement And Strategic Moves Set To Boost Earnings And Market Competitiveness\nThe focus on sustainability and efficiency at the Beihai site could enhance market competitiveness and boost net margins.Is Stora Enso Oyj (HEL:STERV) Using Too Much Debt?\nSep 19Stora Enso Oyj (HEL:STERV) May Have Issues Allocating Its Capital\nSep 01Shareholder Returns\n| STERV | FI Forestry | FI Market | |\n|---|---|---|---|\n| 7D | 6.2% | 4.8% | 1.9% |\n| 1Y | -9.2% | -11.8% | 8.6% |\nReturn vs Industry: STERV exceeded the Finnish Forestry industry which returned -11.8% over the past year.\nReturn vs Market: STERV underperformed the Finnish Market which returned 8.5% over the past year.\nPrice Volatility\n| STERV volatility | |\n|---|---|\n| STERV Average Weekly Movement | 6.7% |\n| Forestry Industry Average Movement | 4.0% |\n| Market Average Movement | 4.2% |\n| 10% most volatile stocks in FI Market | 7.9% |\n| 10% least volatile stocks in FI Market | 2.6% |\nStable Share Price: STERV's share price has been volatile over the past 3 months compared to the Finnish market.\nVolatility Over Time: STERV's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Finnish stocks.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1996 | 19,000 | Hans Sohlstrom | www.storaenso.com |\nStora Enso Oyj provides renewable solutions for the packaging, biomaterials, wooden constructions, and paper industries in Finland and internationally. It operates through Packaging Materials, Packaging Solutions, Biomaterials, Wood Products, Forest, and Other segments. The company\u2019s Packaging Materials segment offers virgin and recycled fiber replace fossil-based materials, renewable and recyclable packaging materials for food and beverage, pharmaceutical, and transport packaging.\nStora Enso Oyj Fundamentals Summary\n| STERV fundamental statistics | |\n|---|---|\n| Market cap | \u20ac8.28b |\n| Earnings (TTM) | -\u20ac116.00m |\n| Revenue (TTM) | \u20ac9.37b |\nIs STERV overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| STERV income statement (TTM) | |\n|---|---|\n| Revenue | \u20ac9.37b |\n| Cost of Revenue | \u20ac6.15b |\n| Gross Profit | \u20ac3.22b |\n| Other Expenses | \u20ac3.34b |\n| Earnings | -\u20ac116.00m |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nOct 23, 2025\n| Earnings per share (EPS) | -0.15 |\n| Gross Margin | 34.39% |\n| Net Profit Margin | -1.24% |\n| Debt/Equity Ratio | 52.3% |\nHow did STERV perform over the long term?\nSee historical performance and comparisonDividends\nDoes STERV pay a reliable dividends?\nSee STERV dividend history and benchmarks| Stora Enso Oyj dividend dates | |\n|---|---|\n| Ex Dividend Date | Sep 24 2025 |\n| Dividend Pay Date | Oct 02 2025 |\n| Days until Ex dividend | 30 days |\n| Days until Dividend pay date | 38 days |\nDoes STERV pay a reliable dividends?\nSee STERV dividend history and benchmarksCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 04:19 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nStora Enso Oyj is covered by 36 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | ABG Sundal Collier |\n| Varun Sikka | AlphaValue |\n| Pierre-Yves Gauthier | AlphaValue |"
    },
    {
      "url": "https://simplywall.st/company/id/8a3231f1-711a-49d1-9395-90e1fe76139e/future?utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo&blueprint=4014254",
      "text": "Pandora Future Growth\nFuture criteria checks 4/6\nPandora is forecast to grow earnings and revenue by 7.9% and 6.5% per annum respectively. EPS is expected to grow by 9.2% per annum. Return on equity is forecast to be 93.5% in 3 years.\nKey information\n7.9%\nEarnings growth rate\n9.17%\nEPS growth rate\n| Luxury earnings growth | 11.9% |\n| Revenue growth rate | 6.5% |\n| Future return on equity | 93.50% |\n| Analyst coverage | Good |\n| Last updated | 18 Aug 2025 |\nRecent future growth updates\nRecent updates\nWhat Does Pandora A/S's (CPH:PNDORA) Share Price Indicate?\nJul 29Pandora (CPH:PNDORA) Looks To Prolong Its Impressive Returns\nJul 16Pandora (CPH:PNDORA) Seems To Use Debt Quite Sensibly\nJul 04A Look At The Intrinsic Value Of Pandora A/S (CPH:PNDORA)\nJun 22Does Pandora (CPH:PNDORA) Deserve A Spot On Your Watchlist?\nMay 29Subdued Growth No Barrier To Pandora A/S (CPH:PNDORA) With Shares Advancing 30%\nMay 17The accessible-luxury jewelry brand Pandora posted 8% same-store sales growth in the U.S. last year.\nU.S. jewelry sales advanced a tepid 1.3% in 2024, driven primarily by price increases as the number of units sold dropped 1.6%, according to industry analyst Edahn Golan of Tenoris.Yet, while AmericanWhen Should You Buy Pandora A/S (CPH:PNDORA)?\nApr 17Why You Should Care About Pandora's (CPH:PNDORA) Strong Returns On Capital\nApr 04Is Pandora A/S (CPH:PNDORA) Trading At A 44% Discount?\nMar 23Pandora's (CPH:PNDORA) Upcoming Dividend Will Be Larger Than Last Year's\nMar 11Getting In Cheap On Pandora A/S (CPH:PNDORA) Might Be Difficult\nMar 02Pandora's (CPH:PNDORA) Solid Earnings Have Been Accounted For Conservatively\nFeb 18Pandora's (CPH:PNDORA) Upcoming Dividend Will Be Larger Than Last Year's\nFeb 10Does Pandora (CPH:PNDORA) Have A Healthy Balance Sheet?\nJan 20Is Pandora A/S (CPH:PNDORA) Potentially Undervalued?\nDec 27Why You Should Care About Pandora's (CPH:PNDORA) Strong Returns On Capital\nDec 03Should You Be Adding Pandora (CPH:PNDORA) To Your Watchlist Today?\nNov 20The Phoenix Strategy Is Elevating Brand Desirability And Driving Revenue Growth\nThe Phoenix strategy is transforming Pandora into a full jewelry brand, boosting brand perception and driving revenue growth through increased store traffic and market expansion.Getting In Cheap On Pandora A/S (CPH:PNDORA) Is Unlikely\nNov 08Pandora A/S' (CPH:PNDORA) Intrinsic Value Is Potentially 87% Above Its Share Price\nOct 27Is Pandora (CPH:PNDORA) A Risky Investment?\nOct 13Is Now An Opportune Moment To Examine Pandora A/S (CPH:PNDORA)?\nSep 16Earnings and Revenue Growth Forecasts\n| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |\n|---|---|---|---|---|---|\n| 12/31/2027 | 38,145 | 6,373 | 6,456 | 9,126 | 16 |\n| 12/31/2026 | 35,661 | 5,792 | 5,704 | 8,262 | 18 |\n| 12/31/2025 | 33,333 | 5,342 | 4,856 | 7,426 | 18 |\n| 6/30/2025 | 32,496 | 5,367 | 6,159 | 8,006 | N/A |\n| 3/31/2025 | 32,193 | 5,363 | 6,491 | 8,244 | N/A |\n| 12/31/2024 | 31,680 | 5,227 | 7,042 | 8,721 | N/A |\n| 9/30/2024 | 30,527 | 4,888 | 6,157 | 7,817 | N/A |\n| 6/30/2024 | 29,996 | 4,837 | 6,129 | 7,713 | N/A |\n| 3/31/2024 | 29,120 | 4,816 | 6,271 | 7,714 | N/A |\n| 12/31/2023 | 28,136 | 4,740 | 5,896 | 7,384 | N/A |\n| 9/30/2023 | 27,172 | 4,576 | 5,203 | 6,638 | N/A |\n| 6/30/2023 | 26,864 | 4,767 | 4,726 | 6,102 | N/A |\n| 3/31/2023 | 26,624 | 4,923 | 4,036 | 5,403 | N/A |\n| 12/31/2022 | 26,463 | 5,029 | 3,243 | 4,434 | N/A |\n| 9/30/2022 | 25,618 | 4,567 | 3,477 | 4,432 | N/A |\n| 6/30/2022 | 25,083 | 4,468 | 3,978 | 4,775 | N/A |\n| 3/31/2022 | 24,583 | 4,527 | 4,794 | 5,433 | N/A |\n| 12/31/2021 | 23,394 | 4,160 | 5,643 | 6,228 | N/A |\n| 9/30/2021 | 22,274 | 4,050 | 5,688 | 6,217 | N/A |\n| 6/30/2021 | 21,616 | 3,758 | 5,605 | 6,108 | N/A |\n| 3/31/2021 | 19,337 | 2,590 | 5,108 | 5,604 | N/A |\n| 12/31/2020 | 19,009 | 1,938 | 5,471 | 5,975 | N/A |\n| 9/30/2020 | 19,074 | 1,885 | 4,529 | 5,117 | N/A |\n| 6/30/2020 | 19,419 | 1,423 | 4,926 | 5,550 | N/A |\n| 3/31/2020 | 21,236 | 2,124 | 5,321 | 6,007 | N/A |\n| 12/31/2019 | 21,868 | 2,945 | 5,963 | 6,775 | N/A |\n| 9/30/2019 | 21,802 | 3,095 | 5,869 | 6,730 | N/A |\n| 6/30/2019 | 22,369 | 4,165 | 5,888 | 6,850 | N/A |\n| 3/31/2019 | 22,495 | 4,683 | N/A | 6,742 | N/A |\n| 12/31/2018 | 22,806 | 5,045 | N/A | 6,624 | N/A |\n| 9/30/2018 | 22,519 | 5,100 | N/A | 6,890 | N/A |\n| 6/30/2018 | 22,731 | 5,515 | N/A | 6,550 | N/A |\n| 3/31/2018 | 22,737 | 5,566 | N/A | 5,912 | N/A |\n| 12/31/2017 | 22,781 | 5,768 | N/A | 6,606 | N/A |\n| 9/30/2017 | 21,780 | 5,915 | N/A | 6,343 | N/A |\n| 6/30/2017 | 21,198 | 5,954 | N/A | 6,266 | N/A |\n| 3/31/2017 | 20,700 | 6,080 | N/A | 6,363 | N/A |\n| 12/31/2016 | 20,281 | 6,025 | N/A | 6,531 | N/A |\n| 9/30/2016 | 19,360 | 5,307 | N/A | 5,088 | N/A |\n| 6/30/2016 | 18,659 | 4,908 | N/A | 4,770 | N/A |\n| 3/31/2016 | 17,930 | 4,597 | N/A | 3,787 | N/A |\n| 12/31/2015 | 16,737 | 3,674 | N/A | 3,384 | N/A |\n| 9/30/2015 | 15,017 | 3,306 | N/A | 3,532 | N/A |\n| 6/30/2015 | 13,951 | 3,025 | N/A | 3,649 | N/A |\n| 3/31/2015 | 12,897 | 2,777 | N/A | 4,379 | N/A |\n| 12/31/2014 | 11,942 | 3,098 | N/A | 4,322 | N/A |\n| 9/30/2014 | 10,803 | 2,830 | N/A | 3,618 | N/A |\nAnalyst Future Growth Forecasts\nEarnings vs Savings Rate: PNDORA's forecast earnings growth (7.9% per year) is above the savings rate (1.6%).\nEarnings vs Market: PNDORA's earnings (7.9% per year) are forecast to grow faster than the Danish market (4.6% per year).\nHigh Growth Earnings: PNDORA's earnings are forecast to grow, but not significantly.\nRevenue vs Market: PNDORA's revenue (6.5% per year) is forecast to grow faster than the Danish market (6.1% per year).\nHigh Growth Revenue: PNDORA's revenue (6.5% per year) is forecast to grow slower than 20% per year.\nEarnings per Share Growth Forecasts\nFuture Return on Equity\nFuture ROE: PNDORA's Return on Equity is forecast to be very high in 3 years time (93.5%).\nDiscover growth companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/24 02:09 |\n| End of Day Share Price | 2025/08/22 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nPandora A/S is covered by 39 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.\n| Analyst | Institution |\n|---|---|\n| null null | ABG Sundal Collier |\n| Mariana Horn Uribe | Berenberg |\n| Melania Grippo | BNP Paribas Exane |"
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/152/undiscovered-gems-with-strong-fundamentals/global?utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo&blueprint=4014254",
      "text": "Results\n4655\nHigh-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.\n4655 companies\nAesler Grup Internasional\nMarket Cap: Rp3.7t\nProvides architectural and construction management services in Indonesia.\nRONY\nRp2,990.00\n7D\n0%\n1Y\n1,310.4%\nXinjiang Torch Gas\nMarket Cap: CN\u00a53.1b\nOperates as a gas service company in China.\n603080\nCN\u00a521.85\n7D\n-1.8%\n1Y\n67.4%\nShandong Sinoglory Health Food\nMarket Cap: CN\u00a52.3b\nManufactures soy proteins in China.\n603182\nCN\u00a514.20\n7D\n-0.2%\n1Y\n43.1%\nShanghai Material Trading\nMarket Cap: CN\u00a55.3b\nEngages in the wholesale and retail of production materials for automobile and chemicals in China and internationally.\n600822\nCN\u00a512.57\n7D\n4.8%\n1Y\n70.6%\nConcord Enviro Systems\nMarket Cap: \u20b911.4b\nEngages in the design, manufacture, installation, operation, and maintenance of industrial water and wastewater treatment, and reuse and zero liquid discharge systems and plants.\nCEWATER\n\u20b9550.50\n7D\n7.1%\n1Y\nn/a\nHangzhou Xili Intelligent TechnologyLtd\nMarket Cap: CN\u00a52.5b\nHangzhou Xili Intelligent Technology Co.,Ltd.\n688616\nCN\u00a514.24\n7D\n2.2%\n1Y\n76.0%\nRenxin New MaterialLtd\nMarket Cap: CN\u00a53.0b\nEngages in the research and development, production, and sale of polystyrene polymer materials in China.\n301395\nCN\u00a512.54\n7D\n2.7%\n1Y\n71.0%\nZHEJIANG DIBAY ELECTRICLtd\nMarket Cap: CN\u00a53.0b\nEngages in the research and development, production, and sale of sealed motors for household, commercial, and vehicle compressors in China and internationally.\n603320\nCN\u00a520.35\n7D\n4.7%\n1Y\n67.4%\nGuangdong Delian Group\nMarket Cap: CN\u00a54.1b\nEngages in the automobile fine chemicals, automobile sales service, and automobile repair and maintenance businesses, and development of new application scenarios in China.\n002666\nCN\u00a55.33\n7D\n2.7%\n1Y\n59.6%\nOriental Precision & EngineeringLtd\nMarket Cap: \u20a9298.3b\nOriental Precision & Engineering Co.,Ltd.\nA014940\n\u20a96,550.00\n7D\n-4.7%\n1Y\n57.1%\nYashima Denki\nMarket Cap: JP\u00a546.4b\nProvides plant business, industry/equipment, and transportation business in Japan and internationally.\n3153\nJP\u00a52,180.00\n7D\n8.7%\n1Y\n39.5%\nHind Rectifiers\nMarket Cap: \u20b928.4b\nDesigns, develops, manufactures, and markets power semiconductors, power electronic equipment, and railway transportation equipment in India and internationally.\n504036\n\u20b91,652.35\n7D\n-13.7%\n1Y\n71.6%\nJinsanjiang (Zhaoqing) Silicon Material\nMarket Cap: CN\u00a52.8b\nEngages in the research and development, production, and sale of precipitated silica.\n301059\nCN\u00a512.27\n7D\n1.1%\n1Y\n50.4%\nMinmetals Development\nMarket Cap: CN\u00a59.9b\nEngages in resource trading, metal trading, and supply chain services in China and internationally.\n600058\nCN\u00a59.22\n7D\n11.9%\n1Y\n55.0%\nTech Semiconductors\nMarket Cap: CN\u00a511.1b\nEngages in the development, manufacture, and sale of power semiconductor devices in China.\n300046\nCN\u00a546.93\n7D\n2.5%\n1Y\n202.8%\nManpowerGroup Greater China\nMarket Cap: HK$1.2b\nAn investment holding company, provides workforce solutions and services in the People\u2019s Republic of China, Hong Kong, Macau, and Taiwan.\n2180\nHK$5.70\n7D\n-0.9%\n1Y\n23.9%\nChongqing Chuanyi Automation\nMarket Cap: CN\u00a510.9b\nResearches, manufactures, and markets industrial auto-control systems and devices, and engineering integration services in China.\n603100\nCN\u00a521.38\n7D\n4.6%\n1Y\n33.8%\nZhubo Design\nMarket Cap: CN\u00a52.8b\nEngages in architectural design and consulting services in China.\n300564\nCN\u00a517.27\n7D\n0.3%\n1Y\n87.7%\nNanfang Ventilator\nMarket Cap: CN\u00a55.2b\nDesigns and manufactures HVAC products in China.\n300004\nCN\u00a510.75\n7D\n28.3%\n1Y\n166.1%\nHangzhou Fortune Gas Cryogenic Group\nMarket Cap: CN\u00a57.6b\nHangzhou Fortune Gas Cryogenic Group Co., Ltd.\n603173\nCN\u00a547.85\n7D\n5.8%\n1Y\n167.2%\nItafos\nMarket Cap: CA$572.0m\nOperates as a phosphate and specialty fertilizer company.\nIFOS\nCA$2.96\n7D\n0%\n1Y\n82.7%\nWholetech System Hitech\nMarket Cap: NT$9.4b\nProvides system integration services in Taiwan, China, and Singapore.\n3402\nNT$129.00\n7D\n4.0%\n1Y\n16.7%\nDaoming Optics&ChemicalLtd\nMarket Cap: CN\u00a56.2b\nEngages in the research and development, production, and sale of reflective materials and products worldwide.\n002632\nCN\u00a59.89\n7D\n5.1%\n1Y\n48.1%\nLelon Electronics\nMarket Cap: NT$14.0b\nDevelops, manufactures, markets, trades in, and sells electrolytic capacitors worldwide.\n2472\nNT$85.00\n7D\n2.2%\n1Y\n9.3%\nLi Ming Development Construction\nMarket Cap: NT$4.3b\nLi Ming Development Construction Co., Ltd.\n6212\nNT$41.95\n7D\n1.7%\n1Y\n-57.0%\nJiangsu Rainbow Heavy Industries\nMarket Cap: CN\u00a56.3b\nJiangsu Rainbow Heavy Industries Co., Ltd.\n002483\nCN\u00a57.10\n7D\n-0.8%\n1Y\n78.4%\nSuzhou Longjie Special Fiber\nMarket Cap: CN\u00a53.4b\nEngages in the research and development, production, and sale of polyester filaments in China and internationally.\n603332\nCN\u00a516.08\n7D\n13.1%\n1Y\n133.7%\nChina New City Group\nMarket Cap: HK$1.6b\nAn investment holding company, engages in the commercial property development and investment for leasing, and commercial operations in Mainland China and internationally.\n1321\nHK$0.85\n7D\n-12.4%\n1Y\n6.3%\nShanghai Chlor-Alkali Chemical\nMarket Cap: CN\u00a59.8b\nManufactures and sells chemical products in China and internationally.\n600618\nCN\u00a510.58\n7D\n3.5%\n1Y\n36.9%\nNeosem\nMarket Cap: \u20a9336.6b\nManufactures and sells semiconductor inspection equipment.\nA253590\n\u20a97,920.00\n7D\n-9.2%\n1Y\n-21.2%\nOuro Fino Sa\u00fade Animal Participa\u00e7\u00f5es\nMarket Cap: R$1.2b\nEngages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.\nOFSA3\nR$22.22\n7D\n-4.8%\n1Y\n-2.1%\nTimex Group India\nMarket Cap: \u20b928.0b\nEngages in designing, manufacturing, and trading of watches in India and internationally.\n500414\n\u20b9277.60\n7D\n0.5%\n1Y\n82.7%\nJagsonpal Pharmaceuticals\nMarket Cap: \u20b915.7b\nEngages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.\nJAGSNPHARM\n\u20b9235.05\n7D\n-4.1%\n1Y\n55.3%\nShenzhen Bsc TechnologyLtd\nMarket Cap: CN\u00a56.8b\nEngages in the design, development, production, and sale of functional devices for electronic products.\n300951\nCN\u00a540.27\n7D\n8.2%\n1Y\n55.5%\nSociete de Limonaderies et de Boissons Rafraichissantes d'Afrique\nMarket Cap: XOF 307.7b\nEngages in the manufacture and sale of beer, soft drinks, mineral water, alcomixes, and energy drink products.\nSLBC\nXOF 18,690.00\n7D\n5.9%\n1Y\nn/a\nLemtech Holdings\nMarket Cap: NT$5.2b\nResearch, develops, produces, and sells precision metal dies and metal stampings in Asia, the Americas, and Europe.\n4912\nNT$79.50\n7D\n-1.6%\n1Y\n-19.3%"
    }
  ],
  "argos_summary": "European markets have risen, buoyed by optimism over U.S. rate cuts and a rebound in euro\u2011zone activity, prompting investors to hunt for undervalued stocks. The article highlights Pandora, Stora\u202fEnso, and Galderma as top picks: Pandora trades at a 35% discount to its DCF\u2011based fair value with strong cash\u2011flow growth but high debt; Stora\u202fEnso is 34% below fair value, offers renewable packaging solutions and expects earnings growth, while Galderma is 44% below fair value, benefiting from robust dermatology earnings and a healthy debt profile. All three companies show attractive valuation metrics relative to peers and analysts\u2019 forecasts, making them compelling opportunities for value\u2011oriented investors.",
  "argos_id": "7IJTUJ3IE"
}